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ABSTRACT
EQUITY OF SOCIAL SUPPORT AND ITS RELATIONSHIP WITH DEPRESSION,
ANXIETY, AND ANTIRETROVIRAL MEDICATION ADHERENCE AMONG
SEROCONCORDANT DYADS OF HIV-POSITIVE AFRICAN AMERICANS AND
THEIR INFORMAL SUPPORTERS
by
Angela Wendorf

The University of Wisconsin-Milwaukee, 2014
Under the Supervision of Professor Katie Mosack
Social support may be an important resource for those coping with stigmatized chronic
illnesses, such as HIV/AIDS, as social support may buffer the deleterious impact of
HIV-related distress (Derlega, Winstread, Oldfield, & Barbee, 2003; Stutterheim, Bos,
Pryor, Brands, Liebregts, & Schaalma, 2011; Ueno & Adams, 2001). Yet little is known
about characteristics of social support among HIV-positive patients in relationships with
other HIV-positive individuals and whether there is an equivalent perception and
provision of support between each patient in the relationship. To examine how equity of
support within the dyad may contribute to nuances in social support, mental health
outcomes, and treatment adherence among HIV-positive individuals, I recruited 34 dyads
comprised of HIV-positive African Americans and their HIV-positive supporters to
complete a survey with measures of perceived social support, equity of support,
relationship factors such as perceived quality of the relationship, depression and anxiety,
and treatment adherence. The results indicate that perceptions of greater perceived social
support from one’s dyadic partner was associated with fewer depressive or anxiety
symptoms. Index patients and informal supporters’ perceptions of source- specific social
support were not related to index patients’ past month medication adherence.

i

Participants’ own and dyad partners’ perceptions of equity (i.e., deviation from equity)
were not identified as significant predictors for any of the outcome variables. There was
no evidence of significant partner effects for any of the study hypotheses. Thus, the
results from this study may be most consistent with an actor-oriented model (Kenny &
Cook, 1999), wherein the participants’ outcomes are a function of the individuals’
perceptions themselves, and their partners’ perceptions have no effect on the individuals’
outcomes. The results from this study indicate the protective effects of individuals’
perceptions of being supported by a specific support person, generalized among a variety
of relationships, on depressive and anxiety symptoms. Future research should explore the
perceptions of support and the rules that may govern relationships among individuals in
HIV-affected relationships to better understand the nuances in social support and their
relation to mental health and treatment outcomes.
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1
Equity of Social Support and its Relationship with Depression, Anxiety, and
Antiretroviral Medication Adherence among Seroconcordant Dyads of HIV-Positive
African Americans and their Informal Supporters

The experience of having a chronic and life-threatening illness can present
considerable psychological challenges related to the trauma of the diagnosis, resultant
physical and functional impairments, and threats to health (Dunlop et al., 2004). In the
case of HIV/AIDS, patients may also be likely to grapple with issues such as responding
to stigma and discrimination, negotiating sexual relationships, and dealing with
uncertainty related to health and medication effectiveness. Patients are also managing
aversive short- and long-term medication side effects (e.g., diarrhea, neuropathy,
lipodystophy, liver disease, and so forth) while being reminded of the need for long-term
medication usage and strict medication adherence to prolong survival. Consequently,
HIV-positive patients are at increased risk for the development of depressive disorders
(Ciesla & Roberts, 2001). Similarly, HIV-positive patients may be at risk for the
development of anxiety disorders, particularly if they have not developed adaptive coping
strategies to deal with HIV-related distress and uncertainty (O’Cleirigh, Hart, & James,
2008).One of the prominent self-care strategies for coping with HIV-related stress and
managing depressive symptoms and anxiety endorsed by HIV-positive patients is seeking
social support from others (Eller et al., 2005; Eller et al., 2010; Kemppainen et al., 2003;
Kemppainen et al., 2006; Kemppainen et al., 2012; Tufts, Wessel, & Kearney, 2009).
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Social Support in the Context of HIV
Social support is conceptualized as interpersonally-provided aid in terms of
emotional, self-esteem, informational, instrumental, and financial resources and
assistance (Berkman, Glass, Brissette, & Seeman, 2000). Although several types of social
support have been proposed in the literature, there are five primary types of social
support that have gained consensus. As described by Cutrona and Suhr (1994; 120) the
primary types of social support include informational support, tangible aid, emotional
support, social network support, and esteem support. The authors describe Informational
Support as “providing information about the stress itself or how to deal with it;” (pg.120)
an example of informational support could be the provision of information by the
patient’s medical doctor for different ways to cope with HIV medication side effects.
Receiving financial assistance from a family member for medical bills would be an
example of Tangible Aid, defined by the authors as “providing or offering to provide
goods or services needed in the stressful situation” (pg. 120). The authors describe
Emotional Support as “communicating love, concern, or empathy” (pg. 120), thus; when
others affirm their love for the patient they are providing emotional support. On the other
hand, Social Network Support, or “communicating belonging to a group of persons with
similar interests or concerns” (pg. 120) might be expressed when a supporter shares
examples of others who have successfully remained adherent to HIV medications.
Finally, when a supporter emphasizes their HIV-positive loved one’s self-worth through
“communicating respect and confidence in abilities,” they are demonstrating Esteem
Support (Cutrona & Suhr, 1994, pg. 120).
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Social support may be an important resource for those coping with stigmatized
chronic illnesses. Social support provided by individuals in the patient’s social network
(i.e. informal supporters) has been proposed to influence the patient’s illness
representation, the process of adjustment to illness, experience of symptoms,
management of symptoms, and adherence to medications (Spirig, Moody, Battegay & De
Geest, 2005). In the context of HIV, social support has been shown to buffer the
deleterious impact of HIV-related distress on individuals’ psychosocial functioning
(Derlega, Winstread, Oldfield, & Barbee, 2003; Stutterheim, Bos, Pryor, Brands,
Liebregts, & Schaalma, 2011; Ueno & Adams, 2001). Furthermore, social support can be
used to manage uncertainty associated with the experience of HIV/AIDS (Brashers,
Neidig, & Goldsmith, 2004), assist with antiretroviral medication adherence efforts
(Hamilton, Razzano, & Martin, 2007; Stumbo, Wrubel, & Johnson, 2011), and instill
hope in patients (Harris & Larsen, 2007).
Social support may be an especially relevant resource for HIV-positive African
Americans who are disproportionately affected by the disease. For instance, although
African Americans comprise 14% of the population, they make up 46% of the HIVpositive population living in the United States, which is an estimated 1.2 million people
(Centers for Disease Control and Prevention [CDC], 2011). Furthermore, African
Americans account for 44% of new HIV infections each year (CDC, 2011). In fact,
African Americans represent the greatest proportion of cases of HIV-positive women,
heterosexual men, injection drug users, and infants (CDC, 2007). Disparities in the
distribution of power and resources and resulting social inequalities that are particularly
prevalent in the African American community (e.g., poverty, decreased access to health
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care, lack of insurance, incarceration) may significantly contribute to increased rates of
HIV infection, poorer health outcomes, fewer coping resources, and increased rates of
emotional distress among African Americans living with HIV/AIDS (Davidson, 2011;
Zierler & Krieger, 1997).
Seeking social support has been identified as a primary self-care behavior among
African Americans living with HIV (Tufts, Wessell, & Kearney, 2009). Support from
others coping with HIV/AIDS may be particularly helpful for patients because of the
social isolation, stigma, and discrimination that people living with HIV/AIDS may
experience (Coates et al., 1987). Peer support has been shown to be an important resource
for coping with HIV and can be even more helpful than family support (Adelman & Frey,
1997; Spirig, 1998; Brashers, Neidig, & Goldsmith, 2004), because people may perceive
friends as being more helpful than family (Serovich, Kimberly, Mosack, and Lewis,
2001). People living with HIV turn to peers for informational support, advocacy,
emotional support, and understanding. Peer support has also been found to facilitate skills
for decision-making and advocating for one’s own health care (Brashers, Haas, Klingle,
& Neidig, 2000; Brashers, Neidig, & Goldsmith, 2004).
Social Support and Depression
Associations between the lack of positive social support and the presence of
unsupportive interactions with depression among HIV positive individuals are evident in
the literature (Siegel, Ravhis, & Karus, 1994, 1997; Ingram et al., 1999; Hays, Turner and
Coates, 1992; Serovich et al., 2001). Among individuals living with HIV/AIDS, the
presence of social support has been associated with fewer depressive symptoms (Ingram
et al., 1999; Metts, Manns, & Kruzic, 1996; Siegel, Karus, & Raveis, 1997). Research
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indicates that perceived and enacted HIV-related social support is inversely associated
with depressive symptoms among HIV-positive women and men, such that lower levels
of actual or perceived support are consistently associated with higher frequency or
severity of depressive symptoms (Carrieri et al., 2003; Fukinishi et al., 1997; Heckman et
al., 2004; Rabkin et al., 1997; Simoni, Huang, Goodry, & Montoya, 2006; Turner, Hays,
& Coates, 1993). Additionally, some researchers have found that perceived social support
has a stronger inverse association with depressive symptoms than enacted support
(McDowell & Serovich, 2007). Being satisfied with the quality of social support has been
associated with a decreased likelihood of depression (Hays, Turner, & Coates, 1992,
Ingram et al., 1999). On the other hand, negative or unsupportive interactions have been
linked with depression among HIV-positive individuals. In a sample of 271 people living
with HIV, Ingram et al., (1999) identified three types of unsupportive interactions
associated with depression; insensitivity, disconnecting, and blaming. Depression may
also create strain and stress in interpersonal relationships within this context, making it
more difficult to obtain continued support from others, resulting in a diminished quality
of support received from others (Knowlton, Curry, Hua, & Wissow, 2009; Schrimshaw,
2002). Consequently, depressive symptoms could be exacerbated if the person living with
HIV/AIDS experiences a loss of support, completing a vicious cycle of diminishing
support and increasing depressive symptoms.
Social Support and Anxiety
Compared to the literature on social support and depression, there has been
considerably less research conducted on the topic of social support and anxiety. Among
individuals living with HIV/AIDS, the most prevalent anxiety-related disorders are
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adjustment disorders with anxiety, generalized anxiety disorder, and posttraumatic stress
disorder (Kerrihard et al., 1999; Kessler et al., 2005). Low partner support has been
identified as a potential predictor of the development of adjustment disorder with anxiety
in HIV-positive men, along with a history of generalized anxiety, and a coping style
characterized by low mastery or control over life events (Dew et al., 1997). More
recently, researchers have examined the differential effects of social support by support
providers on anxiety symptoms for people living with HIV/AIDS. Gordillo and
colleagues (2009) found that emotional support from family and friends has been
associated with lower levels of anxiety symptoms among HIV-positive men and women
living with HIV, but emotional support from partners was not significantly associated
with anxiety.
Most research examining social support and anxiety has been focused on the
realm of fear and anxiety symptom management (Kemppainen et al., 2003; Kempainnen
et al., 2006; Kemppainen et al., 2012) and has included cross cultural samples of people
living with HIV/AIDS in Kenya, South Africa, Norway, Taiwan, and the United States.
Kemppainnen and colleagues (2003) examined perceived causes of anxiety symptoms
and fearfulness among 73 HIV-positive individuals in the United States who reported
anxiety as their most troublesome HIV-related symptom. Participants attributed their
anxiety symptoms and fears to concerns about the personal or existential impact of HIV
(i.e., concerns about being HIV positive, concerns about how the virus was contracted,
worry about HIV as a punishment, concerns about treatments; worry about changing
physical appearance; concerns about the future, fears about death); social relationships
and HIV (i.e., worry about contagion, disclosure, discrimination, losses, concerns about
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the impact HIV has on the family, fearing the responses of healthcare providers; and
concerns related to structural issues (i.e., economics and housing). The most frequent
causes of fear and anxiety were concerns about death and worries about the future
(Kemppainnen et al., 2003). HIV-related death anxiety, a prominent fear described above
and related to death due to HIV illness, has been shown to be modestly and inversely
associated with social support in a recent meta-analysis of 18 studies examining death
anxiety in people living with HIV/AIDS (Miller, Lee, & Henderson, 2012). Thus, social
support appears to have a modest protective effect for the presence of death anxiety.
Seeking social support is a common strategy for the management of HIV-related
fear and anxiety. For instance, in the study conducted by Kemppainen et al. (2003), 21%
of the 73 participants reporting anxiety as their most troublesome HIV-related symptom
in the study reported seeking advice from supportive family members, friends, medical
providers, and HIV-positive peers to cope with anxiety. In a more recent study conducted
by Kemppainen and colleagues (2012), 343 HIV-positive participants from Kenya, South
Africa, and the United States endorsing anxiety as a prominent HIV-related symptom,
reported utilizing social support self-management strategies, including talking with
family and friends (n=199, 58.0%); talking with others (n=144, 42%), and attending a
support group (n=83, 24.2%). Among 502 HIV-positive individuals from Norway,
Taiwan, and the United States who endorsed anxiety as a prominent HIV-related
symptom reported talking with family and friends as a strategy to manage their anxiety
(n=398, 58.25 daily, 32.7% monthly). However, talking with family and friends was only
rated as a moderately effective self-care behavior for anxiety among this sample
(Kemppainen et al., 2006). It is unclear what aspects of seeking support from family and
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friends were beneficial and which were less advantageous for management of anxiety
symptoms.
Social Support and Adherence
Evidence suggests that limited social support (Ammassari et al., 2002; Catz et al.,
2000; Fogarty et al., 2002; Machtinger & Bangsberg, 2005) and less stability of social
support is associated with non-adherence to HIV medications (Johnson et al., 2003). On
the other hand, researchers have found that the presence of positive social support is
related to adherence (Cox, 2009; Gonzalez, et al., 2004; Murphy et al., 2004; Remien et
al, 2003) and satisfaction with social support is related to greater adherence (Vyavaharkar
et al., 2007). Conversely, less stability of social support has been associated with nonadherence to HIV medications (Johnson et al., 2003).
The relationship between social support and adherence may, however, be more
complex than some have demonstrated. For instance, the nature of the relationship
between the support provider and recipient may have differential effects on the
perception of support by the recipient (Johnson et al., 2003; Schwarzer, Dunkel-Schetter,
& Kemeny, 1994; Serovich et al., 2001). Individuals with HIV report perceiving more
social support from partners or friends than from family members (Johnson et al., 2003;
Schwarzer, Dunkel-Schetter, & Kemeny, 1994; Serovich et al., 2001). There are also
complex results when types of relationships, supporter factors (such as HIV status),
characteristics of support, and medication adherence have been examined. For example,
contrary to the general finding that support is predictive of adherence, some have found
that having a primary partner is actually predictive of non-adherence (Johnson et al.,
2003; Knowlton et al., 2011).
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Recently there has been increased attention on the examination of couple-level
variables associated with HAART adherence (Knowlton et al., 2011; Johnson, Dilworth,
Taylor, Darbes, Comfort, & Neilands, 2011). For instance, Knowlton and colleagues
(2011) examined main partner factors associated with adherence to HAART among a
diverse, primarily African American, population of HIV-positive women in Baltimore
and found that medication adherence rates differed drastically between those without a
partner, those with a seronegative partner, and those with a seropositive partner.
Specifically, rates of HAART adherence (self-reported past seven day recall) were
highest (i.e., 92%) for non-partnered women and lowest (i.e., 57%) among those in
seroconcordant relationships, i.e., those in which both members of the couple are HIVpositive. Results from adjusted analyses indicated that “better” (e.g., greater than 90%)
medication adherence was 75% less likely among women in seroconcordant
relationships; moreover, better medication adherence was 78% less likely among women
who relied on their HIV-positive partner for emotional support. Additional analyses
revealed that there was a discrepancy with support needs and support receipt among
women with partners. Overall, 53% of HIV-positive women with either a seropositive or
seronegative partner reported preferences of receiving the most emotional support from
partners; however, only 35% indicated that their partner was indeed their main supporter.
The discrepancy was even greater among women with a seropositive partner (i.e., in
seroconcordant relationships), with 68% of women reporting preferences for their partner
as their main HIV-supporter, and only 32% receiving main HIV-related support from
their partner. Thus, support needs did not appear to be met among this sample of HIVpositive partnered women, particularly among those in seroconcordant relationships.
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When support is enacted by informal supporters, people living with HIV describe
the types of emotional and instrumental support that they receive with respect to
medication adherence, such as coaching, providing medication reminders, monitoring
medication adherence, filling prescriptions, and assisting with medication administration
(Wrubel et al., 2008). Behaviors that are perceived as helpful include those that
demonstrate empathy and teamwork or partnership and behaviors that are perceived as
unhelpful include when support attempts seem intrusive, insincere, dismissive, or
avoidant (Barbee, Derlega, Sherburne, & Grimshaw, 1998; Mosack & Petroll, 2009).
Patients and health care providers have described what this looks like in the HIV/AIDS
health care context when informal supporters attend medical appointments; examples
given for unhelpful support attempts include when the treatment supporter nags the
patient or dominates discussions with health care providers (Mosack & Petroll, 2009;
Mosack & Wendorf, 2011). Even supportive behaviors that informal supporters perceive
to be in the interest of the recipients’ treatment adherence may not be. For instance, Beals
and colleagues (2006) found that caregivers’ reminding HIV-positive patients to take
medications was not significantly associated with medication adherence. Taking these
findings into account, researchers have hypothesized that it may be the unhelpful
interactions between partners that contribute to poor rates of medication adherence
(Johnson et al., 2003).
In summary, although the extant literature on social support in the context of HIV
has largely documented positive associations between social support and positive
physical and mental health outcomes, the mechanisms linking social support with
physical and mental health outcomes and the ways in which social support might
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contribute to negative outcomes remain unclear. Part of the problem may be because
there is an insufficient emphasis on the underlying dimensions of social support; in
particular, on social exchanges (i.e., giving and receiving support) within supportive
relationships. However, it is important to note that there has been scant exploration of the
dimensions of support and exchange of support for individuals in HIV-affected
relationships outside of the context of partnerships; that is, for those in HIV-affected
supportive relationships irrespective of romantic, conjugal, or other familial ties. Indeed,
there are gaps in the literature on social support in the context of broad HIV-affected
relationships, particularly on the transactional nature of social support as related to
mental health and treatment adherence (Wrubel, Stumbo, & Johnson, 2008; Knowlton et
al., 2011). Researchers have hypothesized that unhelpful interactions between partners
may contribute to poor rates of medication adherence (Johnson et al., 2003). However,
the parity of support exchanged in the relationship has not yet, to my knowledge, been
examined in the context of broad seroconcordant HIV-affected relationships. Thus, little
is known about whether there is equivalent receipt and provision of support between each
HIV-positive patient in the relationship.
Equity of Social Support in Relationships
Equity theory suggests that close relationships incorporate a balance of “give and
take” between members of the relationship, and that an imbalance in the support provided
and received is associated with dissatisfaction and negative psychological consequences.
According to this theory, then, an imbalance in support provided and received in the
relationship can have negative psychological consequences such as guilt or
demoralization and can create perceptions of debt or obligation within a relationship due
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to violations of the norm of reciprocity of support (Walster, Walster, & Bersheid, 1978;
Gleason, Iida, Bolger, & Shrout, 2003; Kleiboer, Kuijer, Hox, Schreurs, & Bensing,
2006).
There may be differential psychosocial and emotional consequences based on the
way that individuals within relationships perceive their overbenefitting or
underbenefitting from the support exchange. For instance, when individuals receive more
support than that which they provide (e.g., overbenefitting), they may feel guilty, too
dependent on others, and incompetent to deal with stressors (Liang, Krause, & Bennett,
2001; Lindorff, 2000; Lu & Argyle, 1992) while those providing more support than
receiving (e.g., underbenefitting) may become resentful or experience decreased morale
(Liang, Krause, & Bennett, 2001). Having mutual exchange of support in relationships,
which influences perceptions of equity, has been associated with positive perceptions of
support and better physical and mental health outcomes compared to those with nonreciprocal support in their relationships (Chandola, Marmot, & Siegrist, 2007). Results
from qualitative research conducted with HIV-positive gay couples provide evidence of
participants’ viewing their relationships as more supportive and satisfactory when the
support is balanced between partners and they have opportunities to give and receive
support (Haas, 2002).In an early study exploring opportunities to provide support to
supporters, Hays and colleagues (1990) found that the degree to which HIV-positive gay
men endorsed giving support to members of their social support network was strongly
correlated with their psychological well-being. Qualitative analyses of interview data
from the same study revealed that being able to give support to social network members
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was identified as a helpful support behavior, and that participating in peer support groups
provided an important opportunity to provide support (Hays, Magee, & Chauncey, 1998).
When patients or informal supporters are coping with a chronic illness such as
HIV, the patient’s health status and support needs may influence the balance of support in
their relationships. Indeed, equity of support has been examined in the context of health
status, though to my knowledge not in the context of HIV health status. In general, those
with poorer health status who require more caregiving or support, such as patients in
palliative care, may perceive that they are overbenefitting from support (McPherson,
Wilson, & Murray, 2007). What is unclear, however, is the relationship between health
status and perceptions of differential benefit among those in close relationships in which
both members of the relationship are dealing with an illness such as HIV or AIDS,
considering that care and other forms of support are exchanged between members of the
relationship who are each dealing with a complex illness.
An examination of equity of support (and, conversely, deviation from equity of
support) may help to better explain complex associations between perceived social
support, mental health, and treatment adherence among HIV-positive individuals in close
relationships with other people living with HIV/AIDS. Furthermore, it is important to
examine these issues because an improved understanding of social support mechanisms
contributing to emotional adjustment and treatment adherence could reveal areas for
intervention to affect change at individual (e.g., mental health) and interpersonal levels of
functioning (e.g., communication, interpersonal effectiveness) and address relationship
and treatment adherence issues for HIV-positive individuals supporting others living with
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HIV/AIDS. Results of the present study may be able to lay the groundwork for
development of psychosocial interventions for HIV-positive persons and their supporters.
Present Study
The purpose of the present study was to examine the relationship between equity
and perceived social support with variables including depression, anxiety, medication
adherence, and disease status among seroconcordant dyads of African Americans and
their informal supporters. The present study will draw from populations with a high
burden of HIV. Wisconsin state surveillance reports indicate that 57% of HIV/AIDS
cases are concentrated in Milwaukee County, with 75% of African American HIV cases
being located in Milwaukee County. Significant racial and ethnic disparities exist in
terms of prevalence and risk factors for HIV, with the African American community
being hardest hit by the epidemic. For example, from 2007-2011 in the state of
Wisconsin, African American males were 5-10 times more likely to be diagnosed with
HIV than Caucasian males; while African American women were more than 25 times
more likely to be diagnosed with HIV than Caucasian women. For persons aged 15-29,
77% of cases were African American, and for those 30 or older, 51% of cases were
African American (Wisconsin Department of Health Services AIDS/HIV Program,
2010). Furthermore, recent data indicates that there is extremely high prevalence of HIV
among African American males who have sex with men (MSM) in Wisconsin, with onein-three or 32% of African American MSM being HIV positive (Wisconsin Department
of Health Services AIDS/HIV Program, 2012). A high burden of HIV also exists for
African Americans in Ohio. In 2009, African American adults were 6 times as likely to
be diagnosed with HIV compared to Caucasian adults. African American males were
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approximately 5 times more likely to be living with HIV than Caucasian males, while
African American women were more than 12 times as likely to be living with HIV
compared to Caucasian women (Ohio Department of Health, 2011). In Columbus, Ohio
located in Franklin County, African Americans accounted for 36% of the cases of
individuals living with HIV infection. When the fact that African Americans comprise
only 12% of the state population (Ohio Department of Health, 2011) is taken into
account, the stark disproportionality of the HIV epidemic is evident.
This study has the following specific aims and research goals: (1) To examine
whether equity of support, or perceived equality of support, within seroconcordant dyads
predicts depression, anxiety, and medication adherence above and beyond perceived
social support; and (2) to examine how mismatch in disease status among members of the
dyad (e.g., HIV-positive, no AIDS diagnosis and HIV-positive, AIDS diagnosis) may
predict equity of support, depression, and anxiety among the dyad members. In line with
these aims, I tested several hypotheses to examine associations between variables of
interest and to test prospective models of relations between variables. My specific
hypotheses follow:
Model 1: Perceived Social Support, Support Equity and Medication Adherence
Hypothesis 1: Actor Effects
1. It is hypothesized that greater levels of actor perceived social support and
greater actor equity (lower deviation from equity) will be associated with
greater rates of medication adherence.
Hypothesis 2: Partner Effects
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2. It is hypothesized that higher levels of partner perceived social support will be
associated with higher rates of index patient medication adherence and greater
partner equity (lower deviation from equity) will be associated with higher
rates of medication adherence.
Hypothesis 3: Model Fit
3. It is hypothesized that actor and partner equity of support (as measured by
deviation from equity) will predict medication adherence above and beyond
perceived social support from the dyad partner.
Model 2: Perceived Social Support, Equity, and Depressive Symptoms
Hypothesis 4: Actor Effects
4. It is hypothesized that higher levels of actor perceived social support and
greater actor equity (lower deviation from equity) will be associated with
lower actor severity of depressive symptoms.
Hypothesis 5: Partner Effects
5. It is hypothesized that higher levels of partner perceived social support and
greater partner equity (lower deviation from equity) will be associated with
lower actor severity of depressive symptoms.
Hypothesis 6: Model Fit
6. It is hypothesized that actor and partner equity of support (as measured by

deviation from equity) will predict severity of depressive symptoms above and
beyond perceived social support from the dyad partner.
Model 3: Perceived Social Support, Equity, and Anxiety Symptoms
Hypothesis 7: Actor Effects
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7. It is hypothesized that greater levels of actor perceived social support and
greater actor equity (lesser deviation from equity) will be associated with
lower actor severity of anxiety symptoms.
Hypothesis 8: Partner Effects
8. It is hypothesized that greater levels of partner perceived social support and
greater partner equity (lesser deviation from equity) will be associated with
lower actor severity of anxiety symptoms.
Hypothesis 9: Model Fit
9. It is hypothesized that actor and partner equity of support (as measured by
deviation from equity) will predict severity of anxiety symptoms above and
beyond perceived social support from the dyad partner.
Model 4: AIDS Status Concordance, and Equity, Depressive and Anxiety
Symptoms
Hypothesis 10: Between-Dyads Variable Predictions
10. It is hypothesized that discordant dyad AIDS status (i.e., one partner has a
diagnosis of HIV and the other has a diagnosis of AIDS, representing greater
disease progression) will be associated with greater inequity (greater deviation
from equity), greater severity of depressive symptoms, and greater severity of
anxiety symptoms.
Significance of the Present Study
This study will enable us to better understand the social support mechanisms
which contribute to mental health outcomes and treatment adherence. Once we have a
better understanding of the social support mechanisms that contribute to improved
adherence, we will have a better idea of how to address salient relationship and treatment
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adherence issues for HIV-positive individuals supporting others living with HIV/AIDS,
and be better able to utilize social support in HIV adherence interventions. Moreover,
being able to effect change in treatment adherence over time has the potential to redress
racial disparities in HIV health and health care (Mugavero et al, 2009).
Methods
Design
This study was considered a cross-sectional reciprocal standard design, as both
members of the dyad were measured and each person is a member of only one dyad. This
design allows for the assessment of the variability in responding both between and within
dyads in the present study. Further, the analyses used in the present study allow for the
simultaneous and independent estimation of the effects of each participant’s self report on
both his or her own behavior and their dyad partner’s behavior (Campbell & Kashy,
2002).
Participants
Participants were 34 HIV-positive African American individuals (i.e., “index
patient”) and 34 HIV-positive adults (e.g., partners, family members, or friends; i.e.,
“informal supporters”) from Milwaukee, Wisconsin; Chicago, Illinois; and Columbus,
Ohio. My sample was drawn from high prevalence populations for HIV/AIDS in these
urban locations.
Specific inclusion criteria for the “index patient” include age 18 or older, being
African American, having an HIV diagnosis, being currently prescribed antiretrovirals,
and that they can identify and successfully recruit an adult “informal supporter” who is
also HIV-positive, already aware of the index patient’s HIV status, and who has already
discussed HIV and/or HIV medications with the “index patient.” Inclusion criteria for
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“informal supporters” include being 18 or older, having an HIV diagnosis, and selfidentification as an “informal supporter” for the HIV-positive “index patient.” Only the
index patient member of the dyad must have been African American; the informal
supporter may have been of any ethnicity. Furthermore, dyads did not need to be
romantically involved and I intended to enroll individuals in a broad variety of supportive
relationships. Exclusion criteria included solitary individuals and dyads in which English
was not spoken. Specific exclusion criteria pertaining to the participants’ relationship
included dyads in which there is evidence that the relationship was not a legitimate one
(i.e., information about the type or length of relationship was inconsistently reported by
members of the dyad) or which was not intimate enough (i.e., the members do not talk
regularly), or those in which either individual reported relational violence within that
dyad.
To estimate the sample size required to detect statistically significant differences
in dependent variables consistent with the aims of the study, adequate power to detect
consequential nonindependence must be determined. Consequential nonindependence is
defined as the level at which the intraclass correlation associated with nonindependence
results in a p-value of .10 when it should equal .05 (e.g., a Type I error). The minimum
number of dyads to have adequate power of .80 to detect consequential nonindependence is 35 dyads (Kenny, Kashy, & Bolger, 1998), using a recommended liberal
alpha test value (α=.20, two-tailed; Myers, 1979). As an estimation of the power to detect
statistically significant differences in dependent variables in the study, Kenny, Kashy,
and Cook (2006, p. 180) have indicated that a sample size of 50 dyads may result in a
medium effect size of .5 with power of .64 (adjusted for nonindependence) or .697
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(unadjusted for nonindependence). Taking into consideration concerns about feasibility, a
sample size of 50 dyads was targeted for the pilot study. Due to difficulties obtaining
eligible participants, my sample size is restricted to 34 dyads, which should result in the
ability to detect a large effect size.
Procedure
Institutional Review Board approval was obtained for all aspects of the proposed
study. Participants were recruited from outpatient infectious disease clinics, community
health centers, and community-based agencies providing services to patients with
HIV/AIDS in three Midwestern urban cities, Milwaukee, Wisconsin; Chicago, IL; and
Columbus, Ohio. Recruitment strategies included distributing fliers and handbills,
recruiting through medical provider word of mouth (i.e., discussing study opportunities
with patients and colleagues), and snowball sampling. Potential participants were invited
to call the Patient Advocacy and Research lab at UW-Milwaukee for more information
about the study. After contacting the lab, they were screened over the phone for inclusion
in the study. Participants who identified one individual who would be an appropriate
“informal supporter” for the study and who met other eligibility requirements were
instructed to have the intended informal supporter call the same number in order to also
be screened. Each potential participant was screened separately to determine whether the
dyad was eligible for participation.
Dyads who met eligibility criteria were invited to take part in a larger mixed
methods study, the duration of which was approximately 2 ½ hours. Participants were
asked to bring their HIV medication along to their appointment. During this one-time
visit, dyads were asked to come to a community research center in downtown
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Milwaukee; Chicago, IL; or Columbus, Ohio to complete a self-report psychosocial
survey (approximately 1 ½ hours in length) and an observed communication task
(approximately 30 minutes in length). The survey included questions related to
demographics, treatment adherence, medication adherence self-efficacy, problem-solving
styles, perceived and enacted social support, equity of support, depression symptoms, and
symptoms of anxiety. They were also asked to complete a brief debriefing questionnaire
following the communication task and participate in a brief follow-up phone call in
which they were asked to answer a single survey question. For the purposes of this study,
I analyzed survey responses exclusively. For this survey, the “index patient” and the
“informal supporter” completed identical questionnaires which took approximately 90
minutes to complete.
Questionnaire data were collected on individual, password-protected laptops
using the ACASI (Audio Computer Administered Self Interview) module of QDS
Questionnaire Development System (NOVA Research Company). Survey data was
exported from the QDS survey instrument to a password-protected computer in the
Patient Advocacy and Research Lab. Participants were each paid $30 for their time
following the completion of the study appointment. In addition, child care, bus fare, and
refreshments were available to participants as warranted. Participants received
transportation compensation even if they did not complete the study.
Approximately one week after the completed study appointment, one participant
in each dyad was randomly selected and contacted to answer a follow-up survey question.
The purpose of the follow-up question was to examine test-retest reliability of the equity
survey item corresponding with hypotheses one, two, three, and four. Research staff

22
contacted the participant at the number provided on the consent from and asked them the
follow up question over the phone. Participation in this component took approximately
one minute and participants did not receive any additional compensation for their
participation. Not more than one participant from each dyad was contacted to respond to
this item and only a subset of those who consented to this procedure were contacted.
Materials and Measures
Demographics. Participants were asked to answer basic sociodemographic and
relationship questions including the nature of the relationship between individuals in each
dyad. Specifically, participants reported their age, gender, current relationship status,
race/ethnicity, highest level of education completed, gross monthly income, and number
of children they have. In addition, they reported HIV-related demographic information
such as HIV status, where diagnosed with HIV, year of diagnosis, believed method of
HIV infection, HIV-related services received, most recent CD4 and viral load count, and
HIV-related health care appointment attendance.
Perceived Social Support. To measure participants’ degree of perceived social
support, the Social Provisions Scale (Cutrona & Russell, 1987) was used. Participants
completed both the original (general) questionnaire which asks participants to consider
the degree of social support they perceived in general and the targeted source-specific
questionnaire. For the purposes of this study, only data from the target-specific social
support questionnaire was used, modified for use in the current study by having the target
identified as their dyad partner. On the questionnaire, participants were asked to consider
the degree of support they perceive from the person who accompanied them to the
appointment (i.e., the other member of the dyad). The respondent indicated on a 4-point
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Likert-type scale the extent to which each statement describes his/her current social
network. Responses ranged from 1 (strongly disagree) to 4 (strongly agree). A total score
was computed by summing all items. Higher scores indicate a greater degree of perceived
support. With regard to the validity of the Social Provisions scale, there is good evidence
of discriminant, predictive, and convergent validity (see Cutrona & Russell, 1987;
Russell & Cutrona, 1984).
There is evidence for good convergent validity and acceptable internal
consistency reliability for the Source-Specific Social Provisions scale (Cutrona, 1989).
For this study, internal consistency for the Source-Specific Social Provisions scale was
good with α=.85. For the purposes of my analyses, source-specific perceived social
support (Source-Specific Social Provisions Total Score) was treated as a predictor
variable to test hypotheses 1-9 and as an outcome variable as a test of hypothesis 10.
Equity. To assess equity of support in the dyadic relationship, a one-item measure
modified from Kuijer, Buunk, & Ybema (2001), which was based on the Hatfield Global
Measure of Equity/Inequity (Hatfield, 1978), was used. The item was intended to
measure the equality of support from a give-and-take perspective within the dyad. The
original item used by Kuijer et al. (2001) read, “When you look at your relationship with
your partner, from a viewpoint of give-and-take, how would you describe your
relationship at the moment? The original 5-pt response scale ranged from (1) S/he is
doing a lot more for me I am doing for him/her to (5) S/he is doing a lot less for me than I
am doing for him/her. The item used in this study was modified from Kuijer et al. (2001)
to change the wording from “partner” to “person you came in with today” in order to
reflect the broad nature of relationships among dyads that were recruited. Two anchor
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points were added to the scale, based on personal communication with R. Kuijer (2011)
and to be consistent with the 7-point scale construction of the original Hatfield Goblabal
Measure of Equity/Inequity from which the measure was originally modified. The anchor
points that were added to the scale was “more” and “less”. The actual item in my study
read, “When you look at your relationship with the person you came in with today, from
a viewpoint of give-and-take, how would you describe your relationship at the moment?”
Participants endorsed one of the following options (based on personal communication
from Kuijer et al., 2001), (1) S/he is doing a lot more for me than I am doing for him/her;
(2) S/he is doing more for me than I am doing for him/her; (3) S/he is doing a bit
more for me than I am doing for him/her; (4) S/he is doing as much for me as I am doing
for him/her; (5) S/he is doing a little less for me than I am doing for him/her; (6) S/he is
doing less for me than I am doing for him/her; (7) S/he is doing a lot less for me than I
am doing for him/her. Consistent with Kuijer, Buunk, and Ybema’s (2001)
recommendations, anchor points are recoded for data analyses in such a way that 1 = +3,
2 = +2, 3 = + 1, 4 = 0, 5 = -1, 6 = -2, 7 = -3. For scoring, two linear terms are constructed
to assess deviation from equity and over/underbenefit (Kuijer, Buunk, & Ybema, 2001).
In the current study, the linear term for over/underbenefit was not examined as I was
more interested in the deviation from equity rather than the direction of inequity. For the
linear term of deviation from equity, the original scores representing underbenefit, -3, -2,
and -1 are recoded to +3, +2, and +1, while the positive scores representing equity (0) and
overbenefit remain the same, thus creating a four-point scale ranging from 0 (equity) to 3
(inequity). For the purposes of this study, the linear term of deviation from equity will be
designated as the predictor, and in some cases, the outcome variable.
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No validity data had been reported for the modified equity measure (Kuijer,
Buunk, & Ybema, 2001). The original similarly-worded Hatfield Global Equity measure
(1978) correlates with other measures of equity, however. Sprecher (1986,1988), for
example, found the Hatfield Global measure is positively and significantly correlated
with the Sprecher Global Equity measure (correlations range from r =.45, to .52,
p<.001), which was created to measure day-today equity. Sprecher (2001) also ran
correlations with a multi-faceted measure of equity to the Hatfield Global Measure (with
r’s ranging from .43 to .73).
As this is a one item measure, no internal consistency reliability metric can be
computed. However, test-retest reliability data for the current sample was calculated and
is reported below. To address potential concerns with reliability of the measure, I
randomly selected one member of the dyad approximately one week after the study
appointment to administer this item verbatim as the follow-up question described above.
Responses from the member of the dyad were compared with the original response to
calculate test-test reliability for this item. Results of the test-retest reliability analysis
(N=21) indicate good reliability, Pearson’s r=.48, p=0.03.
For the purposes of my analyses, support equity (from the initial questionnaire
data) was treated as a predictor variable to test hypotheses 1-9 and as an
outcome/dependent variable to test hypothesis 10.
Depression. The severity of depression (i.e., higher total depression scores) was
assessed using the Beck Depression Inventory – Fast Screen (BDI-FS; Beck, Steer, &
Brown, 2000). The BDI-FS is a seven-item self-report inventory designed for the
assessment of depression with medical populations, in which somatic symptoms due to
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the patient’s medical condition may overlap with somatic criteria for depression. Thus, to
minimize potential false positive cases of depression in these samples, the BDI-FS
assesses the cognitive and affective factors of depression which has been recommended
in HIV-positive samples (Kalichman, Rompa, & Cage, 2000; Kalichman, Sikkema, &
Somlai, 1995). Participants marked their response for each item (a symptom of
depression according to Diagnostic and Statistical Manual of Mental Disorders – Text
Revision criteria [DSM-IV-TR]; American Psychological Association, 2000) that best
describes how they were feeling in the past two weeks. Each item is rated on a 4-point
scale, from 0 to 3, corresponding to an increase in severity for the depressive symptom.
Previous research has reported adequate reliability for the BDI-FS, with good internal
consistency (α = .831 in the current study). The BDI-FS has been used in HIV-positive
populations with good validity and reliability. Krefetz and colleagues (2004) examined
the psychometrics of the BDI-FS among a sample of HIV-positive patients with chronic
pain, and found adequate internal consistency (α =.84) using a cut-off of scores greater
4, correctly classified 81% of patients with a depressive disorder, and with 74%
specificity and 90% sensitivity. For this study, good internal consistency for the measure
was observed, α =.83. For the purposes of my analyses, severity of depression (total
depression score) was treated as an outcome variable to test hypotheses 4-6 and 10.
Anxiety. The severity of anxiety (i.e., higher total anxiety scores) was assessed
using the Beck Anxiety Inventory – Fast Screen (BAI-FS; Beck & Steer, 1993). The
BAI-FS is a 7-item self-report inventory designed for the assessment of anxiety with
medical populations, in which somatic symptoms due to the patient’s medical condition
may overlap with somatic criteria for anxiety disorders. Thus, as with the BDI-FS, to
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minimize potential false positive cases of anxiety disorders in these samples, the BAI-FS
assesses the cognitive and affective factors of anxiety which has been recommended in
HIV-positive samples. Respondents marked their response for each item (a symptom of
anxiety according to the DSM-IV-TR; APA, 2000) that they may or may not have
experienced over the past two weeks. Each item is rated on a 4-point scale, from 0 to 3,
corresponding to an increase in the severity of the anxiety symptom. For this measure the
items are simply summed. Beck et al. (1997) found that the sensitivity and specificity
rates for identifying patients with and without anxiety disorders were, 85% and 81%,
respectively, when a BAI-FS total cut-off score of 5 and above was used with 56 patients
seeking medical treatment from family practice medical doctors. The coefficient α of the
BAI-FS total scores with these patients was .90. The BAI-FS has been used in HIVpositive populations with good validity and reliability results. Krefetz and colleagues
(2004) examined the psychometrics of the BAI-FS among a sample of HIV-positive
patients with chronic pain, and found adequate internal consistency (α =.80). For this
study, adequate internal consistency for the measure was observed, α =.91. For the
purposes of my analyses, anxiety severity (total anxiety score) was treated as an outcome
variable to test hypotheses 7-10.
Medication Adherence. To assess HIV medication adherence, a number of
individual items were used, as recommended in the HIV medication adherence literature.
For instance, Lu et al. (2008) compared multiple methods of self-reported HIV
medication adherence with electronic measurement of medication adherence (the “gold
standard” used in many randomized controlled clinical trials to monitor adherence) and
found that a 1-month recall period was associated with less over-reporting of adherence
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and that having patients rate their adherence over the past month was more accurate
compared to having patients rate frequencies or percent of medication taken. Differing in
some respects are Simoni and colleagues (2006) who recommend that investigators ask
participants to self-report their medication adherence in several different ways such as
using a 7-day recall, using normalizing language, and frame the question in different
ways, such as using percentages and scale methods. To incorporate both sets of
recommendations, several questions for self-reported questions were included such as (1)
past 7-day recall of doses taken or missed, (2) percentage of medication taken in the last
month using a visual analogue scale (0-100% with tick marks at intervals of 10), and (3)
rating ability to take medications over the past month (Likert type scale; 1 very poor- 6
excellent). To score item (1), the 7-day adherence was calculated as 1 minus the
proportion of the sum of the missed doses for the 7 days divided by the total possible
number of doses. Item (2) was scored by noting the position of the electronic slider bar
corresponding with their self-rated percent adherence over the past month. Item (3) was a
single value corresponding to the response chosen by the participant on the Likert-type
scale. For the purposes of my analyses, the three medication adherence items were
included in correlational analyses and Item 2, or self-reported medication taken in the
past month, was treated as the medication adherence outcome variable to test hypotheses
1-3.
Data Management and Preparation
After the participants comprising 34 dyads completed the ACASI electronic
survey, data were downloaded from the QDS ACASI server, uploaded into the QDS Data
Warehouse, and imported to SPSS for data management and descriptive analyses. Data
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were then cleaned and screened for missing values and adjusted based on
recommendations for handling missing data (Acock, 2005). Items were summed and
scales were computed for all measures as detailed above.
Data Analytic Strategy
Descriptive statistics were calculated to describe the sample, independent sample
T-tests were conducted to compare index participants and informal supporters with
respect to sociodemographic and illness characteristics, and Pearson’s bivariate productmoment correlations were run to examine associations between variables and to
determine test-retest reliability for the Equity measure. To test hypotheses 1-10,
inferential dyadic analytic methods described by Kenny, Kashy, & Cook (2006) were
used which account for the probable non-independence of the dyadic data.
Dyadic Data Analysis. Data from patients and their partners or other supporters
cannot be assumed to be independent from each other as responses from partners are
often correlated (Kenny et al., 2006). In any close relationship, dyads are likely to share
similar traits or characteristics and characteristics of one member of the dyad may
influence the other member of the dyad. Methods must take into account the nonindependence of dyadic data and should not be based on assumptions of independence of
scores such as traditional multiple regression and analysis of variance approaches (Kenny
et al., 2006).
With dyadic analysis, appropriate data analytic techniques are chosen based in
part of whether the two dyad members can be theoretically or empirically distinguished
or ordered by a variable or factor, such as gender, family role, birth order, or disease
status (Kenny et al., 2006). However, since the participating dyads are a mix of
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distinguishable (e.g., by gender, in the case of a dyad consisting of an HIV-positive male
participant and an HIV-positive female) and indistinguishable (e.g., both male, HIVpositive) subtypes and there is no way to order the members within the dyad, all were
treated as indistinguishable in the analyses (Kenny & Ledermann, 2010).
The Actor-Partner Interdependence Model (APIM) was used as a statistical
framework for examination of the effect that the index participants’ predictor variable
had on their own outcome variable (actor effect) and on the outcome variable of the dyad
partners (partner effect) and vice-versa, while accounting for nonindependence in the
dyad responses (see Figure 1). In this framework, the dyad is the level of analysis and
each member of the dyad has a score on a particular independent or predictor variable, as
well as a score on a particular outcome or dependent variable.

a
X1

Y1
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p

X2
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a
Figure 1. The Actor-Partner Interdependence Model (APIM). “a” represents the actor effect, “p” represents the partner
effect, “X1” and “X2” are the predictor variables for each member of the dyad, and “Y1” and “Y2” are the dependent
(outcome) variables for each member of the dyad. “E1” and “E2” represent the unexplained sources of error influencing
the outcomes. Note, the assignment of 1 and 2 are arbitrary due to the indistinguishable nature of the dyads.
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The APIM analytic approach allows for simultaneous examination of the effects
of the index participants’ and informal supporters’ predictor variables on their pooled
values for the outcome variables (Kenny et al., 2006). For example, when using this
method, it is possible to examine the effects of the respondent’s scores on equity or
perceived social support on their own and on their partner’s outcome variables, such as
depressive symptoms, anxiety symptoms, and medication adherence (partner effect). Due
to the dyad members being indistinguishable in these data, there is only one actor effect
and one partner effect for each predictor variable that contributes to the outcome variable.
If the dyads were distinguishable (e.g., patients and healthy partners; heterosexual
couples only), it would be possible to parse apart an actor effect and partner effect for
each individual. Since the dyads are indistinguishable in this case, it would be arbitrary to
categorically differentiate the two members of the dyad; instead the estimates must be
pooled together (Kashy, Donnellan, Burt, and McGue, 2008).
The APIM analytic approach allows for the testing of three different types of
variables; namely, within-dyad variables, between-dyad variables, and mixed variables
(Kenny et al., 2006). Scores on within-dyad variables are the same across dyads but vary
between dyad members (e.g., gender among heterosexual couples as a categorical withindyads variable), whereas between-dyad variable scores are the same for members of the
same dyad but vary across dyads (e.g., length of romantic relationship); and scores on
mixed variables can vary both within and between dyads in the same study (e.g., both
partners’ reports on their individual depressive symptoms; Kenny et al., 2006). In my
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study, I am examining mixed variables (which are the only types of variables that can be
used in analyses to examine the unique contributions of actor and partner effects) and a
between-dyads variable, AIDS status concordance.
The present study utilizes the APIM to examine the dyadic associations between
equity and perceived social support with mental health (e.g., severity of anxiety and
depressive symptoms) and medication adherence (see Figure 2), as well as dyadic
associations between participant AIDS status concordance with equity, anxiety and
depressive symptoms, and medication adherence (see Figure 3).
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Predictor variables1:
1. Support Equity
2. Perceived Social
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Outcome Variables1:
1. Depression
2. Anxiety
3. Medication Adherence
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Predictor variables2:
1. Support Equity
2. Perceived Social
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1. Depression
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Figure 2. The Actor-Partner Interdependence Model (APIM) as applied to the present study, representative of
hypotheses 1-3. “a” represents the actor effect, “p” represents the partner effect, “Support Equity” and “Perceived
Social Support” are the explanatory/predictor variables for each member of the dyad, and “Depression, ” “Anxiety,”
and “Medication Adherence” are the dependent variables for each member of the dyad. “E 1” and “E2” represent the
unexplained sources of error influencing the outcomes. Note, the assignment of 1 and 2 are arbitrary due to the
indistinguishable nature of the dyads.
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Outcome variables1:
1. Support Equity
2. Depression
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Predictor variable1:
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Figure 3. The Actor-Partner Interdependence Model (APIM) as applied to the present study, representative of
hypothesis 4. “a” represents the actor effect, “p” represents the partner effect, “AIDS status” is the
explanatory/predictor variable for each member of the dyad, and “Support Equity,” “Depression,” and “Anxiety,” are
the dependent variables for each member of the dyad. “E1” and “E2” represent the unexplained sources of error
influencing the outcomes. Note, the assignment of 1 and 2 are arbitrary due to the indistinguishable nature of the dyads.

Multilevel modeling (MLM; also known as hierarchical linear modeling or HLM)
was used to estimate and test the APIM models. MLM has been recommended for
analyses of non-independent indistinguishable dyadic data and this method allows for
model coefficients to be estimated even when data are missing. Furthermore, MLM can
also accommodate several types of dependent outcome variables and can be used to
examine relationships between variables within a hierarchical data structure (Pollack,
1998).
For this study, dyads are considered to represent naturally occurring social groups
of two people each. Within these parameters, there are two levels of data, upper Level 2
(dyad) and lower Level 1 (index participant and informal supporters nested within a
dyad). The two levels are associated with unique modeling of variances; namely, on
Level 1, the variance and relationship between both members of the dyad on an outcome
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variable is modeled and the dyad members’ responses are regressed on a predictor
variable, while on Level 2, the variance in dyad means and dyad-level effects are
modeled (Raudenbush, Brennan, & Barnett, 1995). MLM provides for the estimation of
all model parameters (fixed and random sources of variance) within a single equation
(Cook & Kenny, 2005).
The parameters of the regression model, the intercept (or constant) and slope of
the regression line (or regression coefficient) represent unique characteristics of the
dyadic data. The intercept represents the predicted value of the outcome variable when
the predictor variable score is set to zero (i.e., held constant). Thus, the intercept
represents the grand dyadic mean on the outcome variable. The regression coefficient, or
slope of the regression line, represents the fixed effect; more specifically, the difference
in the outcome variable corresponding for every 1-unit difference in the predictor
variables. The values of the intercept are allowed to vary across dyads, but the slopes are
held equal (or constrained) across dyads (Kenny, Kashy, & Cook, 2006, p. 89). There are
also random effects (or residuals) for the variation in intercepts and error variance. Below
is an example of the Level-1 and Level-2 models to test the APIM with the
indistinguishable dyads in the current study:
Level 1: Yij(MEDADH) = β0j + β1ij (ACT_SSSPSTOT) + β2ij (PART_SSSPSTOT) +
β3ij(ACT_EQDEV) + β4ij (PART_EQDEV)
+ rij
Level 2: β0j = γ00 + V0j
In the Level 1 model above, the notation β0 refers to the nonzero intercept or
constant, while β1, β3, β5, and β7 represent actor parameter coefficients and β2, β4, and β6
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represent partner parameter regression coefficients. The notation i represents the dyad, j
is the individual within the dyad, r is a residual error term, and Y is the outcome variable,
which in this instance is medication adherence. For the Level 2 model, V0j represents a
random dyad effect.
As applied to test the APIM models, multilevel modeling techniques are used to
model scores on dependent variables as a function of the index participant’s and informal
supporter’s scores on predictor variables. Consider the modeling of the index participant
and informal supporter’s depressive symptoms as a function of their equity scores. Using
the APIM model within the MLM analytic context, the index participant’s outcome score
(e.g., depressive symptoms) is regressed onto the index participant’s own predictor
variable score (e.g., equity). Regression coefficients from this aspect of the analysis;
namely, the regression of index participant’s outcome scores (e.g., depressive symptoms)
onto their own predictor variable (e.g., equity) scores represent the mean actor effect for
the predictor variable (e.g., support equity). Concurrently, informal supporters’ outcome
scores (e.g., depressive symptoms) are regressed onto informal supporters predictor
scores (e.g., equity). Regression coefficients from this aspect of the analysis represent
mean partner effects for equity scores. To put another way, actor effects are the influence
of respondents’ ratings on their own outcomes and partner effects are the effects of the
respondents’ ratings on the on the other dyad members’ outcomes. These are main
effects.
Data Structure
The data set for the study analyses was created in SPSS and imported into HLM7
(Raudenbush, Bryk, & Congdon, 2004). The data were structured pairwise, as suggested
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by Cook and Kenny (2005), with each individual participant having their own scores
(actor) and their dyad partner scores (partner) recorded for each variable in the study. In
the data set, each participant had their data recorded in one row, such that there were two
rows for each dyad in the dataset. Each row included dyad ID, the participant’s outcome
scores, and actor and partner values for the mixed predictor variables. Thus, each
participant’s predictor values are entered twice, one as an actor variable for their own
record, and once as a partner variable for the other dyad member’s record. As a special
case, the categorical variable of participants’ AIDS status was dummy coded, designating
values of 0 (no member of the dyad has a current diagnosis of AIDS), 1 (one member of
the dyad has a current diagnosis of AIDS), and 2 (both members of the dyad have a
current diagnosis of AIDS). A between-dyads variable, dyadic AIDS status concordance,
was also created, following similar procedures as Eaton et al., 2009. This categorical
variable was also effect coded, such that dyads with a concordant AIDS status would be
represented with a code of 1 and dyads with a discordant AIDS status would be
represented with a code of -1. The “dyad ID” variable was the linking variable that
signified which individuals were grouped within which dyads (Campbell & Kashy,
2002).
Data Analytic Procedures
The first step in analyzing dyadic data, before testing hypotheses, is to assess
nonindependence of the dyadic data (Kenny et al., 2006). Nonindependence of the
indistinguishable dyadic data was tested by calculating the intraclass correlations for all
of the variables for both the dyad members’ responses. According to Cohen (1988),
intraclass correlations indicating non-independence can range from a small correlation of
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0.1 to a large correlation of 0.5. Nonindependence of the data would also confirm that
MLM is appropriate to estimate the APIM.
For the MLM analyses, all of the predictor and outcome variables were treated as
Level 1 (first level) mixed variables and the dyad identification variable served as the
Level 2 (second level) variable to link the two nested levels of data. As such, the firstlevel predictor variables represented the first-level fixed effects in analyses and the dyad
ID variable represented the second-level random effect to account for possible
correlations in relationship variables across individuals in the same dyad. In the
multilevel modeling process, the first step is to fit a baseline (unconditional) model which
provides estimates of the fixed and random parameters and variance of the intercept
(dyadic mean) and slope (discrepancy score). If there was significant variation in the
slope (discrepancy score) and intercept (dyadic mean), the next step would be to create a
Level 2 model in which the slope and intercept are designated as outcome variables (Bryk
& Raudenbush,1987). Unrestricted maximum likelihood (or full maximum likelihood)
was the method of estimation used in HLM7 to produce estimates of variance and
covariance parameters for each level of the unconditional models, while restricted
maximum likelihood estimation was used to produce estimates of variance and
covariance for the intercept. For all models, residuals for Level-1 variables (as a proxy
for random effects) were assessed for normality within the HLM7 program. Additionally,
each independent variable was grand-mean centered (i.e., subtracting the actual values
from the mean) to minimize multicollinearity of predictors and to allow for
straightforward interpretation of main effects in the regression models. Standard errors,
degrees of freedom, t values, significance testing, alpha levels, and lower and upper 95%
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confidence limits were also provided for each of the parameter estimates in the final
models.
To test hypothesis 1-3, multilevel modeling using HLM7 was conducted to
examine the actor and partner main effects and interactions of the mixed predictor
variables of equity (deviation from equity) and perceived social support (general and
within the dyad relationship) on the mixed outcome variable of self-reported percentage
of medication taken in the last month. Three separate models were created and tested.
The first model I tested was the null model (baseline), which included only the outcome
variable of past month medication adherence and no predictors; the effect of the intercept
was estimated. The second model I tested included only actor values of perceived social
support and partner values of perceived social support as predictors for past month
adherence. I then tested a third model that included actor and partner values for equity (as
measured by the deviation from equity term) because I hypothesized that equity would
predict medication adherence above and beyond perceived social support. To examine
whether the addition of variables at each step resulted in a statistically significant
improved model fit, I conducted likelihood ratio tests, by computing and comparing the
differences between the -2 Log Likelihood values for the different models (Campbell &
Kashy, 2002).
To test hypotheses 4-6, multilevel modeling using HLM7 was conducted to
examine the actor and partner main effects of the mixed predictor variables of equity
(deviation from equity) and perceived source-specific social support (within the dyad
relationship) on the mixed outcome variable of total severity of depressive symptoms.
Three separate models were created and tested. The first model I tested was the null
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model (baseline), which included only the outcome variable of total severity of
depressive symptoms and no predictors; the effect of the intercept was estimated. The
second model I tested included only actor values for perceived source-specific social
support and partner values for perceived social support (within the dyad relationship) as
predictors for total severity of depressive symptoms. For these models, I examined the
contribution of both actor effects and partner effects for the participants’ pooled scores on
the outcome variable of severity of depressive symptoms
I then tested a third model that included actor and partner values for equity (as
measured by the deviation from equity term) because I hypothesized that equity would
predict total severity of depressive symptoms above and beyond perceived social support.
To examine whether the addition of variables at each step resulted in a statistically
significant improved model fit, I conducted likelihood ratio tests by computing and
comparing the differences in -2 Log Likelihood values for the different models
(Campbell & Kashy, 2002).
To test hypotheses 7-9, multilevel modeling using HLM7 was conducted to
examine the actor and partner main effects of the mixed predictor variables of equity
(deviation from equity) and source-specific perceived social support (within the dyad
relationship) on the mixed outcome variable of total severity of anxiety symptoms. Three
separate models were created and tested. The first model I tested was the null model
(baseline), which included only the outcome variable of total anxiety severity and no
predictors; the effect of the intercept was estimated. The second model I tested included
only actor values for perceived social support and partner values for perceived social
support as predictors for total severity of anxiety symptoms. I then tested a third model
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that included actor and partner values for equity (as measured by the deviation from
equity term) because I hypothesized that equity would predict total severity of anxiety
symptoms above and beyond perceived social support. To examine whether the addition
of variables at each step resulted in a statistically significant improved model fit, I
conducted likelihood ratio tests, by computing and comparing the differences in -2 Log
Likelihood values for the different models (Campbell & Kashy, 2002).
To address hypothesis 10, multilevel modeling using HLM7 was conducted to
examine whether the relationship between between-dyads predictor variable of AIDS
status concordance and outcome variables of support equity, severity of depressive
symptoms, and severity of anxiety symptoms differed depending on the influence of the
concordance in dyad AIDS status. Three separate models were created, one for each
combination of predictor (between-dyads variable of AIDS status concordance) and
outcomes (medication adherence, severity of depressive symptoms, severity of anxiety
symptoms). To test hypothesis 10, MLM was conducted to test the main effects of the
dyad members’ AIDS status concordance on the mixed outcome variables of support
equity, depressive symptoms, and anxiety symptoms. If there were potential confounding
variables in the models that were significantly correlated with outcome variables, they
were controlled for in all analyses.
Results
Due to the limited sample size, significant and marginally significant differences
and effects will be reported, so as to not exclude results that might achieve significance
were these relationships tested within a larger sample size.
Demographics and Descriptives
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Sample Characteristics and Descriptives. During the recruitment phase of the
larger mixed methods study from which these data were extracted, 161 individuals (index
patients and informal supporters) called our lab to be screened for study participation; 88
met the eligibility criteria to participate; and 68 individuals (34 dyads) completed the
study. Reasons for ineligibility included participating in a similar previous study, not
identifying as African American or Black (index patient only), not currently taking HIV
medication (index patient only), not having an HIV-positive supporter (index patient
only), reported history of violence within the dyad, being too busy to participate, refusing
to be video recorded, being in bad health, and being out of contact with study staff (e.g.,
having disconnected phone numbers). The final sample included 68 participants
comprising 34 dyads. The majority of the 68 participants were male (48, 70.6%),
although 20 women participated, as well (20, 29.4%). Participants varied in age, from age
22-66 (M=44.0; SD=22). For this HIV-positive sample, 18 participants (26.5%) had a
current comorbid AIDS diagnosis, while the remaining 50 participants (73.5%) were
HIV-positive and did not have a current AIDS diagnosis. Most participants lived at or
below the poverty level, with 52 participants (76.5%) reporting an income of less than
$1000 per month; 8 participants (11.8%) reported receiving $1000-1499 per month, 5
participants (7.4%) reported receiving $1500-1999 per month, 2 participants (2.9%)
reported receiving $2000-2499 per month, and 1 participant (1.5%) reported that their
income was unknown. These descriptive data, along with measures of central tendency
for predictor and outcome variables for models, are displayed in Table 1.
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Table 1. Descriptive summary of sample
Characteristics

Mean (+/- S.D.) or n (%)

Gender
Male

48 (70.6%%)

Female

20 (29.4%)

Age (years)

44.0 (+/- 22.0)

Income
Less than $1000/month

52 (76.5%)

$1000-1499/month

8 (11.8%)

$1500-1999/month

5 (7.4%)

$2000-2499/month

2 (2.9%)

Unknown

1 (1.5%)

HIV status
HIV-positive, no current AIDS
diagnosis
HIV-positive, current AIDS diagnosis

50 (73.5%)

18 (26.5%)

Years since HIV diagnosis known

14.37 (14.76)

Source-Specific Social Support

35.39 (34.38), Range = 15-47

Equity (Deviation from Equity)

1,12 (1.19), Range = 0-3

Beck Depression Inventory-Fast Screen

4.74 (3.85), Range = 0-14

Beck Anxiety Inventory-Fast Screen

7.40 (5.63), Range = 0-19

Medication Adherence (N=58)

86.93% (20.29), Range = 0-100
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Dyad-level attributes. For dyad-level attributes (Table 2), there were three types
of dyads in terms of gender, with 19 male/male dyads (55.9%), 10 male/female dyads
(29.4%), and 5 female/female dyads (14.7%). Dyad members reported being in various
relationship types with each other including romantic relationships, with 8 dyads (23.53%
of dyads) in romantic same-sex relationships, 3 dyads (8.83% of dyads) in romantic
heterosexual relationships, while the majority of participants reported being in platonic
relationships with each other with 21 dyads (61.8% of dyads) in friendships, while the
remaining 2 dyads reported being family members (5.9% of dyads). Dyadic AIDS status
was varied, with 18 dyads (52.9% of dyads) having both members concordant with an
HIV positive diagnosis, but no AIDS diagnosis (i.e., HIV+/HV+), 2 dyads (5.9% of
dyads) with a concordant AIDS diagnosis (i.e., AIDS/AIDS), and 14 dyads (41.2% of
dyads) with a discordant AIDS status (i.e., HIV+/AIDS).
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Table 2. Dyad-level attributes
Characteristics

Mean (+/- S.D.) or n (%)

Gender
Male/male

19 (55.9%)

Male/female

10 (29.4%)

Female/female

5 (14.7%)

Relationship types
Romantic relationships

11 (32.4%)

Same-sex relationships

8 (23.53%)

Heterosexual relationships

3 (8.83%)

Platonic relationships
Friendships

21 (61.8%)

Family members

2 (5.9%)

Dyad AIDS status concordance
HIV+/HIV+

18 (52.9%)

AIDS/AIDS

2 (5.9%)

HIV+/HIV+AIDS

14 (41.2%)

Index patients and informal supporters were compared with respect to sociodemographic
characteristics (see Table 3) and disease characteristics (see Table 4) using Chi-square or
independent sample t-tests as appropriate. Independent sample t-tests were conducted to
examine whether there were differences in sociodemographic characteristics, disease
characteristics, perceived social support, support equity, depressive symptoms, anxiety
symptoms, and medication adherence between index patients and informal supporters.
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The results indicate a significant difference in the past month medication adherence for
index patients and informal supporters who reported being prescribed medication (n=30);
informal supporters rated significantly higher medication adherence (t=-2.18, p=.03) than
index patients.
Table 3. Comparisons between index patients and informal supporters on demographic
and illness variables
Characteristics

Index patient
Mean (S.D.) or
n (%)

Informal
Supporters Mean
(S.D.) or n (%)

t or x2

Age (years)

43.21 (9.21)

45.24 (10.51)

-.85

.40

Years Since HIV Dx

16.20 (19.36)

12.53 (7.77)

Past month
medication
adherence (out of
100)

82.55 (24.73)

93.20 (10.45)

-2.19

.03

Undetectable viral
load

Yes: 16
No: 11

Yes: 18
No: 5

2.06

.15

p

Table 4. Comparisons between index patients and informal supporters on predictor and
outcome variables
Characteristics

Index patient
Mean (S.D.) or n
(%)

Informal
Supporters Mean
(S.D.) or n (%)

t or x2

p

Source-specific social support,
SSSPS

35.32 (6.28)

35.42 (5.39)

-0.07

.94

Depression, BDI-FS

5.29 (4.76)

4.29 (3.59)

.98

.08

Anxiety, BDI-FS

7.70 (5.85)

6.26 (5.57)

1.04

.71

Equity (raw score day of appt)

3.72 (1.92)

4.53 (1.38)

-1.91

.06

Deviation from equity

1.30 (1.34)

1.05 (1.08)

0.83

.41
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Correlational Analyses (test-retest reliability). Pearson correlations were run to
examine the scores on the equity measure (see Table 5) at the time of the study
appointment and at a follow-up date approximately 1-2 weeks after the study
appointment. Results of the zero-order correlations between the two sets of raw equity
scores indicate that the two scores were correlated, r=0.48, p<.05.
Table 5. Correlations among predictor and outcome variables in index patient-informal
supporter dyads
1

2

1 Raw equity scores at appointment

------

------

2 Raw equity scores at one-week followup

.48*

-----

*p<.05; **p<.001
Inferential Analyses/Actor-Partner Interaction Model Analyses
Nonindependence and hierarchical linear modeling assumption testing. Tests
to determine nonindependence for the indistinguishable dyads were conducted by
computing intraclass correlations between scores on predictor and outcome variables
reported by index participants and informal supporters. Results indicated that actor and
partner predictor and outcome variables were not significantly correlated ( r=0.01,
p=.37). However, when considering the sample size required for consequential
nonindependence (at least 35 dyads), Kenny, Kashy, and Bolger (1998) recommend that
the data be treated as nonindependent regardless and dyadic data analysis remains the
appropriate method to use. Tests to examine assumptions of normality, equal variance,
and linearity indicated that the assumptions were met for hierarchical logistic and linear
regression.
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Actor-Partner Interdependence Model analyses. Results for the actor-partner
interdependence model testing for each of the main hypotheses are presented next.
Perceived Social Support, Support Equity and Medication Adherence. For my
first research question, I examined the degree to which equity compared with sourcespecific perceived social support (within the dyad relationship) to predict medication
adherence among participants (N=29 dyads currently on antiretroviral medications). I
used HLM7 to conduct multilevel modeling of the interdependent data for index patient
outcomes. Three hypotheses (1-3) and two models were tested; the first model included
actor and partner values of source-specific perceived social support (i.e., Source-Specific
Social Provisions Scale Total Score) as a predictor for past month medication adherence;
the second model included actor and partner values for deviation from equity as an
additional predictor for index patient past month medication adherence.
The distribution of the medication adherence variable was significantly skewed in
the negative direction, with more participants reporting higher values of medication
adherence in the past month. To address this non-normal distribution, data were
transformed using a log transformation to meet the assumptions of normality inherent in
multilevel modeling. The values that follow are in units of log transformed data.
Results from the testing of the null models, presented in Table 6 indicated a
significant Level 2 dyad effect on the dependent variable of past month medication
adherence (p=<.01). Results from the test of variance components, presented in Table 7,
indicate that there is a trend toward significance for the intercept of the outcome variable
of past month medication adherence being affected by the Level 2 grouping variable of
dyad (variance component =0.01, p=0.07). Furthermore, the variance component for the
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intercept is less than the variance component of the level 1 residual variance component,
indicating that additional variables in the model are needed to predict the remaining
residual variance in the outcome variable of past month medication adherence for both
the index patient and the informal supporter.
Table 6. Null Model 1 Fixed Effects Results: Predicting Past Month Medication
Adherence

Model 1 (Null)
Intercept

Estimate (β)

Standard
Error

t-ratio

1.90

0.04

45.80

p

<.01

Table 7. Final Estimation of Variance Components from Null Model 1: Predicting Past
Month Medication Adherence

Standard
Deviation

Variance
Component

Intercept

0.12

0.01

Level-1, r

0.27

0.07

Random
Effect

x2

39.73

p

0.07

I hypothesized that greater levels of actor perceived social support (from the dyad
partner) and greater actor equity (lower deviation from equity) would be associated with
greater rates of medication adherence in the past month. The estimated coefficient for the
level-1 predictors of actor perceived source-specific social support (i.e., respondents’
perceived support from the other dyad partner), partner perceived source-specific social
support (i.e., the effect of the other dyad members’ perceived support ratings on one’s
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own scores of perceived support) were -0.01 (p=0.87), 0.01, (p=0.20), while estimated
coefficients for the level-1 predictors of actor perceived equity (i.e., respondents’ rating
of equity in the dyad relationship), and partner perceived equity (i.e., the effect of the
other dyad members’ equity rating on one’s own equity rating) were -0.01 (p=0.83), and
0.05 (p=0.16), respectively. The results indicate that neither actor nor partner values of
perceived source-specific social support nor ratings of equity had a significant effect on
the dependent variable of past month medication adherence, according to patient selfreport. Thus, hypothesis one and two were not supported.
To test hypothesis three, that equity of support (deviation from equity) will
predict 30 day medication adherence above and beyond perceived social support, the
goodness of fit of the full model including actor and partner values of Source-Specific
Social Support and Equity predictors was compared to a model only including the actor
and partner values of Source-Specific Social Support (see Tables 8 and 9 for model
parameter estimates). Tests of the deviance statistic indicated that the contribution of the
equity variables to the prediction of medication adherence was negligible (x2=2.16,
p=.34).
Table 8. Model 1 Fixed Effects: The Actor-Partner Interdependence Model
Demonstrating the Actor and Partner Relationships of Perceived Source-Specific Social
Support and Equity to Predict Past Month Medication Adherence

Estimate (β)

Standard
Error

t-value

p

Intercept

1.90

0.04

47.29

<.01

Actor Perceived source-specific support

-0.01

0.01

-0.29

0.77

Partner Perceived source-specific support

0.01

0.01

1.29

0.21

Model 1, Step 2
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Table 9. The Actor-Partner Interdependence Model demonstrating the actor and partner
relationships of perceived social support and equity to medication adherence
Model 1, Step 3
Estimate
(β)

Standard
Error

t-value

p

Intercept

1.90

0.04

47.93

<0.01

Actor Perceived source-specific support

-0.01

0.01

-0.16

0.87

Partner Perceived source-specific support

0.01

0.03

1.32

0.20

Actor Equity (deviation from equity)

-0.01

0.03

-0.22

0.83

Partner Equity (deviation from equity)

0.05

0.03

1.46

0.16

Perceived Social Support, Support Equity, and Depressive Symptoms. For my
second research question, I examined the degree to which equity compared with sourcespecific perceived social support (within the dyad relationship) to predict total severity of
depressive symptoms among participants. I used HLM7 to conduct multilevel modeling
of the data. Three hypotheses (4-6) and three models were tested; the first model which
included the Level 2 grouping variable of dyad as well as the outcome variable of total
depressive symptoms; the second model included the additional variables of actor and
partner values of perceived social support (i.e., Source-Specific Social Provisions Scale
Total Score) as a predictor for total severity of depressive symptoms; the third model
included actor and partner values for equity (i.e., deviation from equity term) as an
additional predictor variable for total severity of depressive symptoms.
Results from the testing of the null models (see Table 10) indicated a significant
Level 2 dyad effect on the dependent variable of total severity of depressive symptoms
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(p=<.01). That is to say, there was a significant main effect for the intercept estimate.
However, results from the test of variance components, presented in Table 11, indicate
that the variance of the intercept of the outcome variable of total severity of depressive
symptoms was not significantly related to the Level 2 grouping variable of dyad
(variance component =0.40 , p=0.40).
Table 10. Null model predicting depressive symptoms among participants - effects

Model 2, Step 1

Estimate
(β)

Standard
Error

t

p

Intercept

4.79

0.52

9.28

<0.01

Table 11. Null model predicting depressive symptoms among participants– final
estimation of variance components

Random Effect

Standard
Deviation

x2
Variance
Component

Intercept

0.63

0.40

Level-1, r

4.17

17.35

34.53

p

0.40

I hypothesized that greater levels of actor perceived social support (from the dyad
partner) and greater actor equity (lower deviation from equity) would be associated with
lower rates of total severity of depressive symptoms. The results of fixed effect testing
(see Table 12 and 13) demonstrated a significant actor effect for perceived social support.
When the other predictor variables in the model were held constant, for every one-point
increase in actor source-specific perceived social support, there was a 0.27 point decrease
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in total severity of depressive symptoms (p=0.01). However, equity as a predictor of total
depressive symptoms was not significant in tests of fixed effects; thus, hypothesis four
was only partially supported. As no partner effects were significant (indicating there was
no effect of the other dyad members’ perceived support or equity ratings on one’s own
rating of depressive symptoms), hypothesis five was not supported.
Table 12. Actor-Partner Interdependence Model demonstrating the actor and partner
relationships of source-specific perceived social support predicting depressive symptoms
Model 2, Step 2

Estimate
(β)

Standard
Error

t

p

Intercept

4.79

0.47

10.25

<0.01

Actor Perceived Source-Specific Social
Support

-0.25

0.09

-2.79

0.01

Partner Perceived Source-Specific Social
Support

-0.06

0.09

-0.63

0.53

Table 13. The Actor-Partner Interdependence Model demonstrating the actor and partner
relationships of perceived social support and equity to depressive symptoms
Model 2, Step 3

Estimate
(β)

Standard t
Error

p

Intercept

4.79

0.46

10.45

<0.01

Actor Perceived Source-Specific Social
Support

-0.27

0.09

-2.98

0.01

Partner Perceived Source-Specific Social
Support

-0.04

0.09

-0.46

0.65

Actor Equity (deviation from equity)

0.62

0.39

1.62

0.12

Partner Equity (deviation from equity)

0.03

0.39

0.09

0.93
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To test hypothesis six, that equity of support (deviation from equity) will predict
total severity of depressive symptoms above and beyond perceived social support, the
goodness of fit of the full model including actor and partner values of Source-Specific
Social Support and Equity predictors was compared to a model only including the actor
and partner values of Source-Specific Social Support (see Table 13 for parameter values).
Tests of the deviance statistic indicated that the contribution of the equity variables to the
prediction of total severity of depressive symptoms was negligible (x2=22.72, p=0.27).
Thus, hypothesis six was not supported and the contribution of the actor and partner
values for equity (deviation) to the predictive model for total severity of depressive
symptoms was negligible.
Table 13. The Actor-Partner Interdependence Model demonstrating the actor and partner
relationships of perceived social support and equity to depressive symptoms
Model 2, Step 3

Estimate
(β)

Standard
Error

t

p

Intercept

4.79

0.46

10.45

<0.01

Actor Perceived Source-Specific Social
Support

-0.27

0.09

-2.98

0.01

Partner Perceived Source-Specific Social
Support

-0.04

0.09

-0.46

0.65

Actor Equity (deviation from equity)

0.62

0.39

1.62

0.12

Partner Equity (deviation from equity)

0.03

0.39

0.09

0.93

Perceived Social Support, Support Equity, and Anxiety Symptoms. The third
research question examined the degree to which equity compared with source-specific
perceived social support (within the dyad relationship) to predict total severity of anxiety
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symptoms among participants. I used HLM7 to conduct multilevel modeling of the
interdependent data. Three hypotheses (7-9) and three models were tested; the first model
which included the Level 2 grouping variable of dyad as well as the outcome variable of
total severity of anxiety symptoms; the second model included the additional variables of
actor and partner values of perceived social support (i.e., Source-Specific Social
Provisions Scale Total Score) as predictive of total severity of anxiety symptoms; the
third model included actor and partner values for equity (i.e., deviation from equity term)
as predictive of total severity of anxiety symptoms.
Results from the testing of the null models indicated a significant Level 2 dyad
effect on the dependent variable of total severity of anxiety symptoms (p=<.01; Table
14). Results from the test of variance components, presented in Table 15, indicate that the
variance of the intercept of the outcome variable of total severity of anxiety symptoms
was not significantly related to the Level 2 grouping variable of dyad (variance
component =0.05 , p=>.5; Table 15).
Table 14. Null model predicting anxiety symptoms among participants – final estimation
of variance components

Random Effect

x2
Standard Variance
Deviation Component

Intercept

0.22

0.05

Level-1, r

5.72

32.66

29.16

p

>0.5

I hypothesized that greater levels of actor perceived social support (from the dyad
partner) and actors’ perception of greater equity (lower deviation from equity) would be
associated with lower total severity of anxiety symptoms. The results of fixed effect
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testing (see Table 15 and 16) demonstrated a trend toward significance for an actor effect
for perceived social support as a predictive of total severity of anxiety symptoms. When
the other predictor variables in the model were held constant, for every one-point increase
in actor source-specific perceived social support, there was a 0.26 point decrease in total
severity of anxiety symptoms (p=0.06). However, equity as a predictor of total anxiety
symptoms was not significant in tests of fixed effects; thus, hypothesis seven was only
partially supported. As no partner effects were significant (indicating there was no effect
of the other dyad members’ perceived support or equity ratings on one’s own rating of
anxiety symptoms), hypothesis eight was not supported.
Table 15. Null model predicting anxiety symptoms among participants - effects

Model 3, Step 1

Estimate
(β)

Standard
Error

t

p

Intercept

6.99

0.69

10.06

<0.01

Table 16. Actor-Partner Interdependence Model demonstrating the actor and partner
relationships of source-specific perceived social support predicting anxiety symptoms
among participants

Model 3, Step 2

Estimate
(β)

Standard
Error

t

p

Intercept

6.99

0.66

10.58

<0.01

Actor Perceived source-specific support

-0.26

0.13

-2.06

0.05

Partner Perceived source-specific support

-0.03

0.13

-0.27

0.79
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To test hypothesis nine, that equity of support (deviation from equity) will predict
total severity of anxiety symptoms above and beyond perceived social support, the
goodness of fit of the full model including actor and partner values of Source-Specific
Social Support and Equity predictors was compared to a model only including the actor
and partner values of Source-Specific Social Support (see Table 17 for model parameter
values). Tests of the deviance statistic indicated that the contribution of the equity
variables to the prediction of total severity of anxiety symptoms was not significant
(x2=0.87, p=>.5). Thus, hypothesis nine was not supported.
Table 17. The Actor-Partner Interdependence Model demonstrating the actor and partner
relationships of source-specific perceived social support and equity to anxiety symptoms
among participants

Model 3. Step 3

Estimate
(β)

Standard
Error

t

p

Intercept

6.99

0.66

10.64

<0.01

Actor Perceived source-specific support

-0.26

0.13

-1.99

0.06

Partner Perceived source-specific support

-0.03

0.13

-0.23

0.82

Actor Equity (deviation from equity)

0.37

0.55

0.68

0.51

Partner Equity (deviation from equity)

0.35

0.56

0.63

0.53

AIDS Status, and Support Equity, Depressive and Anxiety Symptoms. The
fourth research question was focused on whether the relationship between AIDS status
concordance and outcome variables of equity, severity of depressive symptoms, and
severity of anxiety symptoms differed depending on the concordance of dyad AIDS
status among participants. I used HLM7 to conduct multilevel modeling of the
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interdependent data. One hypothesis (10) and three models were tested. The betweendyads variable of dyad concordance was created by assigning dummy codes to dyads for
AIDS status concordance, with 0 signifying discordant dyads and 1 signifying concordant
dyads. This variable was included as a level 2 variable in the regression models. Results
of fixed effects (see Tables 18, 19, and 20) did not demonstrate significant effects for
dyad AIDS status concordance on the outcome variables of equity, total severity of
depressive symptoms, or total severity of anxiety symptoms, thus Hypothesis 10 was not
supported.
Table 18. The Actor-Partner Interdependence Model demonstrating AIDS status
concordance as a between-dyads variable predictor of equity (deviation from equity)
among participants
β

Standard Error

t

p

Intercept

1.26

0.25

5.06

<0.01

AIDS status concordance

-0.13

0.32

-0.42

0.68

Table 19. The Actor-Partner Interdependence Model demonstrating AIDS status
concordance as a between-dyads variable predictor of depression among participants
β

Standard Error

t

p

Intercept

4.54

0.82

5.56

<0.01

AIDS status concordance

0.44

1.06

0.41

0.69

Table 20. The Actor-Partner Interdependence Model demonstrating AIDS status
concordance as a between-dyads variable predictor of anxiety among participants
β

Standard Error

t

p

Intercept

6.71

1.09

6.17

<0.01

AIDS status concordance

0.46

1.42

0.32

0.75
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Discussion
The aim of this study was to better understand whether HIV-positive individuals’
and their HIV-positive supporters’ perceptions of support availability and balance (i.e.,
equity) within their relationship are associated with their own and their supporters’
mental health and treatment-related health outcomes. Using the Actor-Partner
Interdependence Model as a conceptual framework and hierarchical linear modeling as
the statistical approach, the relationships between perceived source-specific social
support and equity with depressive symptoms, anxiety symptoms, and medication
adherence for index patients and their self-identified informal supporters were examined.
In this study, there was evidence of significant actor effects of perceived support
from one’s dyadic partner (i.e., source-specific social support) on total depressive
symptoms and total anxiety symptoms, as hypothesized. Specifically, greater perception
of dyadic social support was associated with fewer depressive or anxiety symptoms.
Although there is a dearth of research examining source-specific social support among
dyads with chronic illness (and no research examining source-specific social support for
dyads in supportive relationships coping with HIV), the closest proxy may be the
perception of partner or spousal support from studies in which one member of the couple
has a chronic illness, most commonly cancer. My findings are consistent with others’
research, such as Gremore and colleagues (2011) who found negative relationships
between partner support and depressive symptoms among women coping with breast
cancer and their healthy partners. In a similar vein, Lal & Bartle-Haring (2011) found that
partner unsupportive behavior was positively associated with depression among patients
with chronic lung disease. Findings from psycho-oncology literature suggest a negative
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relationship between perceived family support and psychological distress among patients
and healthy spouses coping with prostate and breast cancer (Baider, Ever-Hadani,
Goldzweig, Wygoda, & Peretz, 2003). When researchers have examined general social
support in the context of patients and their healthy partners coping with chronic illness,
they have found such social support was negatively associated with psychological
distress (Barry, Kasl, Lichtman, Vaccarino, & Krumholz, 2006; Thomson, Molloy, &
Chung, 2012.
Contrary to my expectations, participants’ perceptions of source- specific social
support were not related to participants’ past month medication adherence. The
relationship between social support and HIV medication adherence in the literature has
been documented as largely positive (Andersen et al., 2000; DiMatteo, 2004; Persson,
Ostgergren, Hanson, Lindgren, & Naucler, 2002), wherein greater perceptions of social
support have been associated with greater rates of medication adherence. Conversely,
there is literature indicating negative or neutral associations between perceived support
and HIV medication adherence (Johnson et al., 2003; Knowlton et al., 2011). In the
current study, it may be that the statistically insignificant results are due to neutral effects
of the support perceived from their dyad partner, or due to low power to detect effects.
The literature also shows us that not all support is created equal and there may be
variability in the relationships between support and adherence based on the supporter and
the perception of the nature of support for adherence. For instance, Wrubel, Stumbo, &
Johnson (2010) have examined the dynamics of received support among serodiscordant
and seroconcordant couples with HIV. The results of their qualitative interviews reveal
variability in the attributions of who provides support for adherence; whether adherence
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is viewed as a personal responsibility or couple responsibility depended on support
preferences and the support exchange context of relationships. Thus, it may be that
participants in our study tended to identify adherence as a personal responsibility and
perceived support did not play a significant role with respect to their medication
adherence. Moreover, relationship partners may be sought for particular types of support.
For example, Stumbo, Wrubel, & Johnson, (2011) found that HIV-positive individuals
sought instrumental or tangible support from their partners while receiving and seeing
informal and emotional support from family members and friends. Although the sample
size is too small to examine support and adherence patterns by relationship type, we
might consider that index participants were not as reliant on supporters for adherencerelated support based on their relation with the supporter.
Contrary to what I hypothesized, there was no evidence of significant partner
effects for any of the study hypotheses. Thus, the results from this study may be most
consistent with an actor-oriented model (Kenny & Cook, 1999), wherein the participants’
outcomes are a function of the individuals’ perceptions themselves, and their partners’
perceptions have no effect on the individuals’ outcomes. These results may be due to the
nature of the dyads, in which both individuals are simultaneous coping with their own
illness. Thus, participants may be more individually focused on their own coping with
illness and there may be less carryover in terms of how their perceptions of social support
and equity influence their supporters’ mental health and treatment outcomes. Most of the
literature examining mental health and treatment outcomes in a dyadic context
incorporates patients and their healthy partners or caregivers, where there are distinct
roles and supporters are often focused on the patient and their outcomes. In addition, a
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larger sample size for the current study may have increased the likelihood of detecting
partner effects.
Surprisingly, participants’ own and dyad partners’ perceptions of equity (i.e.,
deviation from equity) were not identified as significant predictors for any of the outcome
variables. Although there is no research examining associations between equity and
medication adherence, there is literature that supports associations between perceptions
of inequity and psychological distress (Kuijer et al., 2001; Ybema, Kuijer, Buunk,
DeJong, & Sanderman, 2001; Ybema et al., 2002). Perhaps an examination of reciprocity
of support exchange (i.e., the balance between received and provided support
transactions) rather than global perceptions of equity may better capture the negative
effects of inequitable support (Kleiboer et al., 2006). On the other hand, researchers have
argued that meeting partner needs in intimate relationships may be more important to
individuals than having equity of support in the relationship (Clark & Mills, 1979; Clark
& Chrisman, 1994). Another possibility to consider is the concept of equity preferences;
that is, individuals’ preferences for equity in their relationships. For instance, dyadic
relationships may be set up in a way that one partner may be more comfortable giving
support while the other partner may be more comfortable receiving support. Future work
should incorporate an examination of equity preferences and equity agreements in
relationships. Additionally, others have argued that perceptions of inequity may be more
closely associated with relationship quality than with distress (Kuijer, Buunk, DeJong,
Ybema, & Sanderman, 2004). To address this issue, future work should include measures
of relationship quality into studies assessing the relationship between equity,
psychological distress, and treatment outcomes.
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Additionally, the non-significant results may be due to the way in which equity
was measured as a global assessment and not a more discrete measurement. Investigators
have also examined aspects of equity through use of author-derived scales assessing
perceptions of underinvestment and perceptions of underbenefit (Ybema et al., 2001) and
examining reciprocity of emotional and instrumental social support exchanges as a proxy
for equity through diary or daily report studies (Gleason, Iida, Bolger, & Shrout, 2003;
Kleiboer et al., 2006). Future studies should incorporate multiple measures of equity and
reciprocity to gain a more comprehensive understanding of the nuances with respect to
balance of support in relationships with respect to mental health and treatment outcomes.
The assessment of equity should also occur at multiple time points. For example, the item
in the current study is focused on perceptions of equity “at this moment” or the day of the
appointment. A more stable assessment of equity might be obtained if participants were
asked to consider the equity in their relationships over the past month, past year, and so
forth. This may, in part, explain why the correlation between the equity ratings at the time
of the appointment and one week later was not very strong. Additionally, the power
issues may be associated with the lack of significance. With regard to future analyses of
this data, it would be interesting to examine associations between the raw scores on the
equity measure and outcome variables, as index patients and informal supporters differed
on this score and the distribution would have more variability with the 7-point scale
compared with the 4-point scale for deviation from equity.
Finally, there were no significant predictor effects of AIDS status concordance on
the outcome variables of equity, depressive symptoms, or anxiety symptoms among
dyads. Although there was a sizable proportion of dyads in our sample with a discordant
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dyads AIDS status, perhaps their difference in AIDS status was did not play the most
prominent role with respect to mental health and equity in the relationship. It may be the
case that a more specific operationalization of discrepancy in health status or
multifactorial assessment of health status was needed; this might be inclusion of
symptom burden, health-related quality of life, functional limitations, or number of
AIDS-defining conditions or complications as a way to assess the significance of
participants’ health status. It may also be the case that when there is a discrepancy in
health status and one partner in the dyad has pressing health needs, equity may not be as
much of a concern and needs-based rules for the relationship may dominate (Clark &
Mills, 1979; Kuijer et al., 2001). Alternatively, perhaps examining concordance in a
construct such as supporter burden or supporter role overload might better capture the
relationship to mental health and equity in the relationship. For instance, significant
caregiver burden and role overload have been described among HIV-positive caregivers,
and have been associated with deleterious mental health outcomes and compromised selfcare and management of HIV (Edwards, Irving, & Hawkins, 2011; Folkman et al., 1994;
Land & Hudson, 2004; Land, Hudson, & Stiefel, 2003; Wight, 2000). Although burden
and role overload associated with the provision of informal support was not examined
explicitly in the present study, it may be an important area for future exploration with
respect to equity and mental health in seropositive dyads. Furthermore, given the
spectrum of relationship types representing in our sample (i.e., ranging from friendships
to intimate relationships), the impact of a differential health status may not be as
powerful on patients’ or supporters’ mental health and perceptions of equity in the
relationship. The small sample size precludes further subdivision to examine the potential
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differences in the relationships between AIDS status concordance, mental health, and
equity by relationship type; however, future research is recommended to examine
differences in these constructs.
Limitations
Although findings from my study contribute to an understanding of equity and
social support within HIV-affected relationships, there were several significant
limitations that may have influenced the results. One such limitation pertains to the
sample size. The sample size was small and as a result, there was reduced power to detect
large effects. Specifically, I was only able to detect small effects which required a large
difference. Although dyadic data analysis using multilevel modeling has been conducted
with small samples, it is often the case that these studies too may have been
underpowered. With additional participants, I would expect to find stronger relationships
between key variables of interest.
There are a number of factors that may limit the generalizability of these results,
including response biases common to self-report measures (e.g., erroneous recall and
social desirability responding). Another issue affecting generalizability may be a selfselection bias due to the way in which dyads were recruited and enrolled in the study. For
instance, index patients did the recruiting of the informal supporters and it is possible that
the index participants perceived a more close relationship with the supporter than vice
versa. However, we did attempt to minimize this by doing extensive screening of both
partners to try to ensure that they were in a mutually supportive relationship of
significance and free of abuse. Additionally, the participants in this study were quite
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impoverished which may have influenced their perceived support (e.g., reduced financial
support) and the relevance of perceived equity versus getting their needs met.
Additionally, the way in which the construct of equity was measured in this study
may be a limitation. The use of a single item measure is not ideal. In future studies,
inclusion of multiple methods of assessment of equity within the dyad will be
implemented. Additionally, a construct that has been discussed as distinct from equity,
but related, is reciprocity of support or the perception of returning support to others.
Perhaps reciprocity may be relevant in this context of shared HIV illness and an
interaction between equity and reciprocity on the outcome variables may have been
observed. Future inclusion of the assessment of reciprocity in this line of research is
recommended.
Finally, we utilized a cross-sectional research design for this project. Thus, causal
inferences between perceived source-specific social support, equity, depressive
symptoms, anxiety symptoms, and medication adherence cannot be established. That is to
say, social support could improve mental health outcomes, but positive mental health
could also influence how supportive one sees those around him or her. Longitudinal
research is recommended to examine how the relationships between these variables may
change over the course of coping with HIV/AIDS. Despite these limitations, there is still
important information to be gained from this research, which holds promise for future
research investigations and clinical practice.
Implications, Future Directions, and Conclusion
Little is known about how the nuances and contextual factors associated with
social support influence mental health and medication adherence outcomes in the context
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of HIV. The present study was the first to examine, in a dyadic context, perceptions of
equity among members of supportive relationships who are both HIV-positive. In fact,
this study was the first to my knowledge to examine equity among dyads diagnosed with
the same illness. Most investigators have examined coping and adjustment to chronic
illnesses for patients and their healthy caregivers or healthy spouses. The results from this
study indicate the protective effects of individuals’ perceptions of being supported by a
specific support person, generalized among a variety of relationships, on depressive and
anxiety symptoms.
These results, although tentative, may imply that perceptions of support from
important support persons of patients with HIV/AIDS are important with respect to
mental health outcomes. Informal supporters who are also seropositive may be
particularly useful supporters for people living with HIV/AIDS as they may be a source
of peer support and education. Providers should work with patients when assessing their
social support network, to identify potential supporters and in particular, supporters who
may be HIV-positive.
Additional research is needed to learn how patients assess and evaluate support
and equity within the relationship (e.g., whether certain forms of support contribute more
to perceptions of equity than others), whether optimal matching of support plays a role
with respect to perceptions of equity, and the mechanisms by which equity influences
mental health, adherence to medication, and treatment engagement more broadly.
Longitudinal research is recommended to examine changes in perceived equity and its
relationship with mental health and treatment outcomes over time. Qualitative research
examining the nature of various types of supportive HIV-seropositive relationships is
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recommended to gain a better picture of the nuances in perceptions of support and the
rules that may govern these relationships, whether it be having the perception of an
equitable relationship, one in which individuals have their needs met, or some other type
of dynamic that may be operating. Considering that these participants were living at or
below the poverty level, it may be the case that getting their needs met, and obtaining
instrumental or tangible forms of social support, may be more relevant than perceiving
that the give and take within the relationship is equal. These and many other research
questions are waiting to be answered.
Conclusions
The receipt and provision of informal support and informal caregiving in the
context of HIV/AIDS is common, particularly among populations that are
disproportionately affected by the illness, such as African Americans. Yet, there remains
much to be explored about the exchange and perceptions of support within close
relationships of those coping with HIV/AIDS while providing support to others. If we are
to gain a better understanding of how to utilize social support outside of the medical
context to positively affect medical outcomes, we must examine the nuances of social
support within these close relationships to understand their impact on individuals’ and
their supporters’ mental health and treatment outcomes. This research is one of many
steps toward a better understanding of the support dynamics within broad HIV
seroconcordant relationships.
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Appendix B. HIV Communication Survey (Selected Items Used in Dissertation
Research)
PI: Katie E. Mosack, Ph.D.; Student Co-PI: Angela R. Wendorf
Note: Survey is administered via QDS (ACASI) software and participants do not see
question numbers or skip pattern directives, below.
Thank you for agreeing to participate in our study. We appreciate your time and
honesty; your responses will help us improve and understand HIV treatment
planning for those diagnosed with HIV/AIDS and their loved ones. Please be aware
that some questions will be about your experiences with HIV. For others, we will ask
you your thoughts about the experiences of the person who came with you today. If
you have any questions as you complete this survey, please ask the interviewer.
Demographics
1. What year were you born?
2. What month were you born?
3. What is your age in years?
4. What






is your gender?
Male
Female
MTF Transgender
FTM Transgender
Other (please specify) ____

5. What





most closely defines your current relationship status?
Not dating
Dating casually
In a committed relationship
Other (please specify) ___________________
_

________________

6. With which race and/or ethnicity do you identify (select all that apply):
 White/Caucasian
 Black/African American
 Hispanic/Latino /a
 Asian or Pacific Islander
 Native American
 Other (please specify): _____________
_______
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7. What










is the highest level of education you have completed? (select one)
Grade School
Some High School
Finished High School or High School Equivalent (GED)
Some College (no degree)
Earned Associates Degree
Earned Technical Degree
Earned a Bachelor’s Degree
Earned a Master's Degree
Earned Doctorate/Medical/Law degree

8. Considering all sources of income, how much do you take home each month
(gross income)?
 0 (I did not receive or make any money)
 $1-499/month
 $500-999/month
 $1000-1499/month
 $1500-1999/month
 $2000-2499/month
 $2500 or more/month
9. Do you have any children?
 Yes
 No
If “No”, skip Question 10 and 11, and continue to Question 12.
continue to question 10

If “Yes”,

10. How many do you have?
11. How many children live with you?
Now, we would like to ask you about ask you about your health, health care,
medical appointments, your relationship with your doctor, and your experiences
with medications. In all cases, we ask you to focus on your care and treatment as it
relates to HIV.
12. Have you ever been tested for and/or diagnosed with HIV?
 Yes
 No
If “no” skip questions 13 – 42 and continue to question 43. If ‘yes” continue to
question 13.
13. What is your current HIV status (choose one)
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 HIV-positive, currently diagnosed with AIDS
 HIV-positive, no current AIDS diagnosis
i. If you answered “HIV-positive, no current AIDS diagnosis,” have
you ever been diagnosed with AIDS?
 Yes
 No
14. Where were you diagnosed?
 STD clinic
 Planned Parenthood
 Primary Care Physician’s Office
 Community Health Center
 Health Department
 Hospital
 Blood bank
 Emergency Room/Urgent Care
 While locked up (e.g., jail, prison, detention facility)
 Other (please specify):
15. In what year were you diagnosed with HIV?
 19
 20
 I don’t remember the year*
*If you don’t remember exactly what year you were diagnosed, please
estimate the year you may have been diagnosed:
16. In what month were you diagnosed with HIV?
Medication Adherence
17. Each time you take your medications we consider that to be a dose. How many
doses of your HIV medications do you take each day?
 1 dose
 2 doses
 3 doses
If you answered 1 dose answer question 33, then continue to question 37.
If you answered 2 doses answer question 34 and 35, then continue to question 37
If you answered 3 doses answer question 34, 35, and 36 then continue to question 37
18. Of the 7 doses you were supposed to take during the last week, how many did you
miss?
 1
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2
3
4
5
6
7

19. Of the 7 morning doses you were supposed to take during the last week, how
many did you miss?
 1
 2
 3
 4
 5
 6
 7
20. Of the 7 evening doses you were supposed to take during the last week, how
many did you miss?
 1
 2
 3
 4
 5
 6
 7
21. Of the 7 afternoon doses you were supposed to take during the last week, how
many did you miss?
 1
 2
 3
 4
 5
 6
 7
22. Many patients find it difficult to take all their HIV medication exactly as
prescribed. Put a mark on the line below at the point that shows your best guess
about how much of your prescribed HIV medication you have taken in the last
month. We would be surprised if this were 100% for most people.
Example: 0% means you have taken no medication
50% means you have taken half your medication or all your medication about half the
time
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100% means you have taken every single dose of your medication

10

20

30

40

50

60

70

80

90

100

23. During the past month, rate your ability to take all your medications as prescribed
 Very poor
 Poor
 Fair
 Good
 Very Good
 Excellent
Anxiety Symptoms
Assessed with the Beck Anxiety Inventory – Fast Screen/Primary Care)- Sample items
are not reproduced.

Depressive Symptoms
Assessed with the Beck Depression Inventory – Fast Screen – Sample items are not
reproduced.

Source-Specific Perceived Social Support
In answering the next set of questions, please think specifically about your current
relationship with the person who came with you today. As a reminder, none of the
information that you provide will be shared with this person. Thank you again for
your honesty.
24. Please indicate to what extent each statement describes your current relationship
with the person that came with you today. Use the following scale to indicate your
opinion: So, for example, if you feel a statement is very true of your relationship
with the person that came with you today, you would respond with “strongly
agree.” If you feel a statement clearly does not describe your relationship, you
would respond with “strongly disagree.”

I can depend on him/her to help if I really need it.

Strongly
Disagree


Disagree


Agree


Strongly
Agree
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I feel that I could not turn to him/her for guidance in times
of stress.
S/he enjoys the same social activities that I do.

















I feel personally responsible for his/her well being.









I feel s/he does not respect my skills and abilities.
If something went wrong, I feel that s/he would not come
to my assistance.
My relationship with him/her provides me with a sense of
emotional security and well-being.
I feel my competence and skill are recognized by him/her.
I feel s/he does not share my interests and concerns.





































I feel s/he does not really rely on me for their well-being.
I could turn to him/her for advice if I were having
problems.
I feel I lack emotional closeness with him/her.

























Perceived Equity of Support
25. The next question is about the give-and-take that goes on in the relationship
between you and the person you came in with today. We want you to judge
the give-and-take (for instance doing things for each other, listening to each
other, and talking about each other’s problems) in your relationship.
1. When you look at your relationship with the person you came in with today
from a viewpoint of give-and-take, how would you describe your relationship?
Please check one option.






He/she is doing a lot less for me than I am doing for him/her
He/she is doing somewhat less for me that I am doing for him/her
He/she is doing as much for me as I am doing for him/her
He/she is doing somewhat more for me than I am doing for him/her
He/she is doing a lot more for me than I am doing for him/her

Thank you for your honest responses. We appreciate your participation in the
survey. At this time, please inform the interviewer that you are ready for the next
portion of the study.
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Internship in Clinical Psychology (APA-accredited)
8/26/2013-8/22/2014
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Veterans Affairs Palo Alto Health Care System, Behavioral Medicine Track
Current Rotations:






Behavioral Medicine: Assessment, consultation, and intervention with
veterans who are medical or surgical patients
o Behavioral Medicine Clinic: Responsibilities include assessment and
intervention with veterans referred for behavioral problems related to
illness; treatment of anxiety, depression, or other mental health
conditions related to medical problems
o Hepatitis C Clinic: Responsibilities include assessment of veterans
who are being considered for antiviral treatment of HCV and
intervention for those who are currently on treatment; work within an
interdisciplinary team
o Hematology/Oncology Clinics: Responsibilities include assessment
and intervention for patients with hematological or oncological
disorders/disease; consultation/liaison; coordination and integration
with multidisciplinary teams
Inpatient Spinal Cord Injury Unit: Responsibilties include conducting
evaluations and interventions with patients eith spinal cord injuries; conduct
screening of cognitive assessment and administer neuropsychological tests;
provide care within well-integrated interdisciplinary team within the
rehabilitation setting
Upcoming Rotations (02/21/2014-08/22/2014):
o Infectious Disease/HIV clinic, Smoking Cessation, MOVE TIME
(weight loss intervention and bariatric clinic) First Step (90 Day
Residential Substance Abuse Rehabilitation Program), Acceptance and
Commitment Therapy Mini Rotation

Health Psychology Practicum Student (Extern)
5/2012-12/2012
Medical College of Wisconsin/Froedtert Hospital, Wauwatosa, WI
 Training in clinical health psychology/behavioral medicine within the
Department of Transplant Surgery
o Responsibilities include conducting psychological evaluations and
follow-up for potential lung transplant candidates (d/t cystic fibrosis,
chronic obstructive pulmonary disease, emphysema); providing
inpatient consultation and interventions to hospitalized transplant
candidates; and consulting with the transplant medical team
 Supervisor: Rebecca C. Anderson, Ph.D.
Health Psychology Practicum Student (Extern)
09/2011-8/27/2012
University of Wisconsin Hospitals and Clinics, Department of Orthopedics and
Rehabilitation, Madison, WI
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Training in clinical health psychology/behavioral medicine within a physical
rehabilitation department.
o Responsibilities included providing psychological services such as
intake assessments, individual therapy, and group therapy to medical
outpatients in an outpatient health psychology department. Facilitated
support groups for patients coping with various chronic illnesses (e.g.,
neurological disorders, pulmonary disorders, diabetes, obesity,
fibromyalgia, tinnitus). Created program curricula for new
psychotherapy groups for patients with medical illnesses.
o Interventions included cognitive behavioral therapy, behavioral
activation for depression, acceptance and commitment therapy, and
cognitive-behavioral stress management.
Supervisor: Heidi Beckman, Ph.D.

Health Psychology Practicum Student (Extern)
06/2010-08/2011
Medical College of Wisconsin/Froedtert Hospital, Wauwatosa, WI
 Department of Trauma and Critical Care Surgery
o Responsibilities included consultation/liaison with members of the
medical trauma team and providing psychoeducation and individual
cognitive-behavioral therapy to inpatients in a Level I trauma center.
Other responsibilities included screening for mental status, acute stress
disorder, and administering behavioral medicine-focused assessments
to medical inpatients who experienced traumatic events and medical
injuries.
o Supervisor: Terri deRoon-Cassini, Ph.D.
 Department of Transplant Surgery
o Responsibilities included providing individual cognitive-behavioral
therapy to adult outpatients and medical inpatients awaiting or
adjusting to liver, kidney, pancreas, or lung transplants; conducting
psychological evaluations for potential liver, kidney, and pancreas
transplant candidates; conducting psychological evaluations for living
kidney donors; co-facilitating support groups for patients awaiting
kidney transplants; co-facilitating support groups for patients who
have received liver, kidney, and pancreas transplants; and consultation
with the transplant medical team. Other responsibilities included
administering diagnostic and behavioral medicine focused assessments
to potential transplant candidates and living donors, providing followup on assessment results and the treatment plan for transplant
candidacy, and report writing.
o Supervisor: Rebecca C. Anderson, Ph.D.
 Departments of General Surgery and Plastic and Reconstructive Surgery
o Responsibilities included providing individual therapy for medical
patients with posttraumatic stress disorder, and health and behavior
interventions to adult clients with comorbid medical illness (e.g.,
diabetes, morbid obesity, chronic pain, Crohn’s disease, ulcerative
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colitis, non-epileptic seizures), conducting psychological evaluations
and health behavior interventions for potential bariatric surgery
candidates, and collaboration with the outpatient medical teams.
o Interventions included cognitive behavioral therapy, Behavioral
Activation for Depression, and Cognitive Processing Therapy
o Supervisor: Mark Rusch, Ph.D.
Graduate Student Therapist
05/2009-5/2013
Practicum in Therapy, Psychology Clinic, University of Wisconsin-Milwaukee,
Milwaukee, WI
 Training in adult and child outpatient therapy. Responsibilities include
providing individual therapy to adult, adolescent, and child clients. Presenting
concerns include mood disorders, insomnia, adjustment disorders, and social
skills deficits. Interventions include: Behavioral Activation for Depression,
Acceptance and Commitment Therapy, Dialectical Behavior Therapy Skills
Training (individual format), CBT for Insomnia, and Affirmative Counseling.
Additional responsibilities include administering assessment measures to
potential clients.
Supervisors: Gwynne O. Kohl, Ph.D.; Jonathan W. Kanter, Ph.D.
Clinical Psychology Practicum Student
9/2007-5/2009
Psychology Clinic, University of Wisconsin-Milwaukee, Milwaukee, WI
 Training in clinical interviewing, scoring, and report writing. Received
training in empirically supported treatments for DSM-IV diagnoses.
 Received training in administration of psychological and neuropsychological
assessment instruments for adults, clinical interviewing, scoring, and report
writing.
 Training in the administration of child assessment instruments and projective
instruments, clinical interviews, assessment scoring, integrative report writing,
and classroom observation; emphasis on cultural and ethnic diversity.
Provided assessment services and consultation to an Individualized Education
Plan team at a local charter school
TEACHING EXPERIENCE
Project Assistant, Undergraduate Research Apprenticeship Program in Psychology,
UW-Milwaukee. 7/2008-6/2011.


Developed and led structured discussions on topics related to research and
professional development in psychology for undergraduate research assistants,
facilitated interactive group discussion and presentation of research, answered
questions, mentored and advised students
Teaching Assistant, Introductory Psychology UPace, UW-Milwaukee, 9/07-5/08,
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Facilitated web based instruction, monitored and provided individualized
feedback on student progress in the online course, advised students, provided
assistance with course material via email or face to face discussions, served as
student-professor liaison
Teaching Assistant, Introductory Psychology, UW-Green Bay, 9/06-12/06,


Developed and led exam review sessions, presented a lecture, served as a studentprofessor liaison
Study group leader, Introductory Psychology, UW-Green Bay, 9/06-12/06


Developed and led structured discussions, answered questions, reviewed course
material, and helped students prepare for exams on a weekly basis
________________________________________________________________________
PROFESSIONAL AFFILIATIONS
American Psychological Association (APA)
Member of Division 38 and 45
Association for Behavioral and Cognitive Therapies (ABCT)
Member of Behavioral Medicine Special Interest Group
Society of Behavioral Medicine (SBM)
______________________________________________________________________
PROFESSIONAL ACTIVITIES
National Organization Leadership



Graduate Student Chair, Educational and Training Council, Health Psychology
(Div. 38, 2009-5/2012)
Member, Behavioral Medicine Program Committee (ABCT, 2009-2010)

University Leadership




Student Representative, Clinical Training Committee, UWM Clinical Psychology
Program (May 2012-May 2013)
Grant Committee, Association for Graduate Students in Psychology (9/20075/2013)
Grant Committee, Health Psychology Graduate Student Club (9/2008-5/2013)

